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Both supervised and unsupervised physical activity programs have successfully increased physical 
activity and reduced body weight when combined with a standard behavioral weight management 
program. However, it remains unclear if supervised and unsupervised physical activity programs 
with similar activity prescriptions change physical activity behavior and physiological responses 
comparably. Purpose: The primary aim of this study was to examine changes in moderate-to-
vigorous physical activity (MVPA) in response to a supervised physical activity program 
prescribed in minutes/week (SUP-PA), an unsupervised physical activity program prescribed in 
minutes/week (UNSUP-PA), and an unsupervised physical activity program prescribed in 
steps/day (STEP) during a standard behavioral weight loss intervention. Methods: Fifty-two 
overweight and obese adults (age: 43.5 ± 10.1 years, BMI: 31.5 ± 3.5 kg/m2) were randomized to 
STEP (n=18), UNSUP-PA (n=17), and SUP-PA (n=17). Subjects were prescribed a calorie-
restricted diet (1200-1800 kcals/day) and increased physical activity (150 min/week or 10,000 
steps/day with 2,500 brisk steps/day). All three groups attended weekly in-person group 
intervention sessions for 12 weeks. Results: All three groups significantly increased MVPA in 
bouts of ≥10 minutes over the 12-week intervention (STEP: 11.5 ± 31.2 min/day, UNSUP-PA: 
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16.1 ± 25.8 min/day, and SUP-PA: 21.6 ± 24.9 min/day, p<0.001) with no differences between 
groups (p=0.94) or group by time interaction (p=0.81). In addition, there were no significant 
differences in weight loss between the groups (p=0.81). Conclusions: This study provides 
evidence that unsupervised physical activity prescribed in minutes/week and an unsupervised 
physical activity program prescribed in steps/day can increase physical activity equally compared 
to a supervised physical activity program during a standard behavioral weight loss program 
eliciting similar physiological responses in adults who are overweight or obese.
 v 
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PREFACE 
“Lack of activity destroys the good condition of every human being, while movement and 
methodical physical exercise save it and preserve it.” - Plato 
 
 
 
xiv 
 1.0  INTRODUCTION 
1.1 BACKGROUND 
Approximately  69% of the U.S. adult population is overweight, defined by a body mass 
index (BMI) of ≥ 25.0 kg/m2, and 35% are obese (BMI ≥ 30.0 kg/m2), with the prevalence of 
overweight and obesity rising drastically over the past several decades.1,2 Obesity increases the 
risk of several chronic diseases, including heart disease, metabolic syndrome, type II diabetes, and 
some forms of cancer.3-5 In the United States, the burden of obesity related health problems is 
extremely costly with associated annual health care costs rising over 147 billion dollars.6 
Therefore, identifying and improving treatment strategies to prevent the negative health 
consequences associated with this disease are critically important. 
One treatment strategy that is typically recommended to people who are overweight or 
obese is physical activity. Regular moderate-to-vigorous physical activity (MVPA) is associated 
with reduced health risk that may be present with obesity.7-9 Public health recommendations for 
aerobic physical activity include 150 minutes of moderate intensity per week, 75 minutes of 
vigorous intensity per week, or an equivalent combination of both intensities for all adults.10 This 
recommendation seeks to maximize health benefits with an attainable physical activity goal. Yet, 
nearly half of U.S. adults are not participating in the recommended amounts of aerobic physical 
activity according to self-report questionnaire.11 Using objective measures, even fewer adults are 
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 participating in the recommended amounts of MVPA, with Troiano et al. reporting less than 5% 
of U.S. adults achieving 30 minutes of MVPA per day.12 In addition to the health benefits 
associated with physical activity (e.g., fitness, glucose control, blood pressure, mood, etc.), 
physical activity is also important for weight management.13,14 However, only 40.6% of U.S. adults 
trying to lose or maintain weight follow recommendations to engage in at least 150 minutes per 
week of physical activity according to self-report measures.15 Identifying strategies to support 
sustained, health-enhancing physical activity participation continues to be a major public health 
priority, especially in adults who are overweight and obese.8,9  
The manner in which physical activity is prescribed and monitored may influence physical 
activity engagement. Within the context of clinical research, physical activity has been prescribed 
in either a supervised or unsupervised manner. Supervised physical activity is typically done in a 
health-fitness facility under the direct supervision of trained staff. With this method, adherence to 
the physical activity prescription (e.g., duration, frequency, intensity, and type) can be closely 
monitored and verified. However, supervised physical activity requires qualified health-fitness 
staff and can be expensive and inconvenient for the participants.16,17 This is of concern because, 
within the general population, commonly reported barriers to physical activity include lack of time, 
disruptions to routine, and lack of access to facilities, which limits the generalizability of 
supervised physical activity trials.18 Thus, the use of supervised activity within clinical research 
may not reflect the participation that would be observed in a non-research setting, and therefore 
the physiological and health benefits may vary. 
An alternative method is to prescribe physical activity in an unsupervised manner, which 
promotes physical activity participation in a setting that is convenient to the individual. This may 
be more advantageous for people reporting the aforementioned barriers. Unsupervised activity can 
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 be done in any environment or at any time that best suits the individual. This provides scheduling 
flexibility, which may enhance adherence to the physical activity prescription. Additionally, 
unsupervised physical activity programs require less staff and are less expensive compared to 
supervised physical activity programs.19,20 This has resulted in many clinical research studies 
implementing unsupervised activity programs which may reflect a “real world” scenario, with 
these programs prescribing activity in minutes per day or with a daily step goal. Because these 
programs are unsupervised, they are often considered inferior to supervised physical activity 
programs when evaluating the physiological effects of physical activity. However, it remains 
unclear if an unsupervised physical activity program yields similar benefits compared to a 
supervised physical activity program of the same prescribed dose.  
Comparisons of supervised physical activity programs versus unsupervised physical 
activity programs in an overweight and obese population have previously been studied with 
inconsistent results.21-24 For example, Craighead and Blum concluded that, within a standard 
behavioral weight loss program (SBWP), the supervised physical activity group had greater weight 
loss and improvement in cardiorespiratory fitness compared to the unsupervised physical activity 
group.23 In contrast, Perri et al. reported that unsupervised physical activity was superior to group-
based physical activity in terms of physical activity participation, adherence, and weight loss 
outcomes after 1 year of weight loss treatment.22 Andersen et al. reported that within a 16-week 
SBWP, both supervised and unsupervised physical activity produced similar effects of decreased 
body weight, decreased body fat,  improved cardiorespiratory fitness, decreased blood pressure, 
decreased cholesterol, and decreased triglycerides.21 After the 16 week intervention, participants 
were followed for one year, with participants in the supervised exercise group regaining 1.6 kg 
compared to a 0.08 kg in the unsupervised exercise group. Furthermore, the unsupervised group 
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 maintained cardiorespiratory fitness levels while the supervised group significantly decreased 
fitness.21 Another trial, conducted by Leermakers et al. found that there was no difference in 
physical activity participation or weight loss outcomes between a home-based (unsupervised) and 
a clinic-based (supervised) weight loss program which included physical activity.24  
A limitation of these previous studies is that the unsupervised conditions relied on self-
report to confirm adherence to the prescribed dose of physical activity.21-24  Moreover, these 
studies did not necessarily assess other components of physical activity that may contribute to 
energy expenditure (e.g., sedentary behavior, light intensity physical activity, other lifestyle forms 
of physical activity), and therefore may impact weight loss or other health-related outcomes.    
Thus, to properly compare the effects of supervised and unsupervised physical activity programs 
on physical activity and the resulting physiological changes, objective monitoring of physical 
activity may provide important insights that inform the observed results. While valuable 
information can be gained from these previous trials, no study to date has utilized objective 
monitoring of physical activity to compare the effects of supervised and unsupervised physical 
activity programs on physical activity engagement in adults who are overweight or obese 
participating in a SBWP. 
1.2 SIGNIFICANCE AND THEORETIC RATIONALE 
Few U.S. adults are meeting the recommended amount of physical activity.11,12  Improving 
physical activity participation is an important health message for all U.S. adults. However, 
improving physical activity participation in an overweight and obese population could have even 
greater benefits because physical activity may offset some of the negative health consequences 
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 associated with excess body weight. Physical activity improves cardiorespiratory fitness,19,21,22,25-
29 blood pressure,19,26,28,30 waist circumference measures,25-28body composition,25-28,31 and weight 
loss.14,27,32,33 Pertinent to this proposed study is that the addition of physical activity to an energy 
restricted diet within the context of a SBWP increases weight loss achieved by approximately 0.5 
to 3.0 kg within the initial 6 months of the intervention.33,34 Thus, the inclusion of physical activity 
within a SBWP can have numerous health-related benefits, one of which is improved weight loss, 
in adults who are overweight or obese. Improving weight loss and other health-related parameters 
could greatly reduce the burden associated with overweight and obesity. Thus, it is imperative to 
explore strategies to enhance physical activity participation in an overweight and obese population. 
Altering the physical activity prescription is one strategy that may influence participation. Figure 
1 represents the theoretical framework of this study and how weight and health related outcomes 
are impacted by the physical activity prescription.  
 
Figure 1. Theoretical Rationale 
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 Two common intervention approaches to increase physical activity participation are 
prescribing supervised physical activity or unsupervised physical activity. Within a research 
setting, and in some clinical settings (e.g., cardiac rehabilitation), supervised physical activity 
programs have been preferred because of the ability to monitor compliance to prescribed amounts 
of physical activity, which allows for accurate quantification of dose of physical activity exposure.  
Supervised physical activity interventions produce quantifiable study results because the 
physical activity is closely monitored and controlled for duration, intensity, frequency, type, or 
energy expenditure. The benefits of supervised physical activity programs have been well 
documented including improvements in MVPA, 19,21,22,25-29 cardiorespiratory fitness, 19,21,22,25-29 
blood pressure, 19,26,28,30  abdominal adiposity, 25-28 and body composition.25-28,31 Additionally, 
supervised physical activity programs offered in a health-fitness setting limit some barriers to 
activity (e.g., weather, walkability, safety, access to equipment, etc.) that are typically reported in 
unsupervised programs. While considered the “gold standard” to quantify physical activity 
exposure, supervised activity programs have many limitations. These limitations include: 1) the 
need for additional staff to supervise the activity sessions, 2) the need for facilities in which to 
conduct these supervised activity sessions, 3) the lack of generalizability outside of the research 
environment for participants who otherwise would not have access to a supervised program, 4) the 
additional barrier of traveling to a facility to complete physical activity 5) the lack of studies to 
quantify compensation or changes in physical activity occurring outside of the supervised sessions 
that could either enhance or blunt the observed responses.35  
An alternative is to prescribe physical activity that allows participants to engage in the 
activity in an unsupervised manner, which is a typical clinical approach (i.e., a physician will 
simply instruct a patient to become more physically activity). Moreover, to allow for enhanced 
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 generalizability and to reduce the cost, unsupervised physical activity programs are also used 
within research studies. These have also been shown to be effective for improving health-related 
outcomes (e.g., fitness, body composition, etc.).19,21,22,29,36,37 Because this type of programming 
allows for greater flexibility on the part of the participant (e.g., when and where they can be active, 
etc.), one could hypothesize that this may lead to greater physical activity participation when 
compared to supervised programs. In fact, there is some evidence that adherence to unsupervised 
physical activity programs may be better than supervised physical activity;29,37 however, adherence 
has typically been measured using self-report measures, which are subject to several biases. 
Moreover, these comparisons have not assessed physical activity outside of the supervised 
sessions, which could affect health outcomes.  Thus, additional research on unsupervised and 
supervised physical activity prescriptions is needed using objective measures of physical activity, 
particularly within the context of SBWP.  
Unsupervised physical activity can be prescribed in several ways (e.g., minutes/week, 
steps/day, kcals/day, etc.) When directly comparing the effects of an unsupervised physical activity 
program versus a supervised physical activity program, the activity should be prescribed in a 
similar manner. Consistent with the national guidelines for physical activity, most programs use a 
minutes/week prescription.  However, another method of prescribing unsupervised physical 
activity is based on steps taken per day, typically based on pedometer counts or other similar 
devices. This type of physical activity may provide even more flexibility than other activity 
prescriptions. The increased flexibility may further promote adherence and lead to a reduction in 
sedentary behavior since the physical activity does not need to be done in specific bouts with any 
opportunity to walk and increase steps counting towards the physical activity goal for the day.  
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 Previously studies in which physical activity was prescribed as steps per day have shown 
limited impact on cardiorespiratory fitness, which is commonly reported as a benefit of increasing 
physical activity.26,38,39 This may be a result of steps per day recommendations not including 
further guidance on the intensity at which those steps are to be taken.  Thus, the effect of steps/day 
prescriptions that have been previously evaluated only focused on total steps per day and not on 
the intensity of the steps.26,38-44 Moreover, prior studies evaluating the effect of steps per day have 
not directly compared this physical activity prescription to either supervised or other unsupervised 
physical activity prescriptions.  
Knowing the effects of unsupervised physical activity is important because of the 
translation of this type of physical activity to non-research settings. Therefore, knowing the 
magnitude of the physiological effects of unsupervised physical activity compared to supervised 
physical activity at the same prescribed intensity and dose is of clinical and public health 
importance. This study is designed to provide insight on these important research questions that 
can inform future research and the application to clinical, public health, and health-fitness settings. 
1.3 SPECIFIC AIMS 
This study engaged subjects in a SBWP with a common diet intervention and subjects were 
randomized to the following physical activity conditions: 
1. Supervised physical activity (SUP-PA) 
2. Unsupervised physical activity with the dose matched to the prescription of SUP-PA 
(UNSUP-PA) 
3. Unsupervised physical activity with the dose prescribed as steps per day (STEP)  
8 
 These intervention conditions was used to test the following aims. 
1. The primary aim of this study was to compare SUP-PA, UNSUP-PA, and STEP for 
changes in moderate-to-vigorous physical activity (MVPA) accumulated in bouts of 
≥10 minutes.  
2. Additional aims included comparing SUP-PA, UNSUP-PA, and STEP for changes in: 
a. Sedentary behavior, light-intensity physical activity, and steps per day. 
b. Cardiorespiratory fitness 
c. Body Weight  
d. Body Composition (Fat-Free Mass, Fat Mass, Percent body fat, waist 
circumference)  
e. Resting blood pressure 
f. Self-efficacy for physical activity and perceived self-efficacy to continue 
physical activity beyond the intervention period. 
g. Energy intake and eating behaviors 
1.4 HYPOTHESES 
1. It was hypothesized that MVPA (accumulated in bouts of ≥10 minutes) would differ 
by group across the intervention with SUP-PA > UNSUP-PA and SUP-PA > STEP. 
Rationale: Supervised physical activity programs are considered the gold standard. 
Because an exercise physiologist was monitoring and verifying exercise intensity and 
duration for SUP-PA, we hypothesized that this group would engage in the highest amount 
of MVPA. It was hypothesized that the other groups (UNSUP-PA, STEP) may report 
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 engaging in similar amounts of MVPA compared the SUP-PA group, however, the 
intensity of this physical activity may not reach the moderate threshold reducing total 
MVPA time.  
2. Hypotheses for additional aims included: 
a. Sedentary time would differ by group with STEP < SUP-PA and UNSUP-PA < 
SUP-PA across the intervention, and light-intensity physical activity would differ 
by group with STEP > SUP-PA and UNSUP-PA >SUP-PA across the 
intervention. 
Rationale: Because the STEP group had a total volume of activity goal (e.g., 
10,000 steps/day) it was hypothesized that the STEP group would engage in less 
sedentary behavior and more light intensity physical activity compared to SUP-PA. 
Similarly, it was hypothesized that the UNSUP-PA group would reduce sedentary time 
because this unsupervised group may also increase lifestyle activities. This increase in 
lifestyle activity would also increase light intensity physical activity. Additionally, the 
SUP-PA group may have compensated for the increases in MVPA by increasing 
sedentary time according to the ActivityStat Hypothesis.35 Thus, it was hypothesized 
that UNSUP-PA and STEP would engage in less sedentary behavior and more light-
intensity physical activity compared to SUP-PA.  
b. Cardiorespiratory fitness would differ by group with SUP-PA > UNSUP-PA and 
SUP-PA > STEP across the intervention. 
Rationale: Supervised physical activity programs are considered the gold 
standard. Because an exercise physiologist was monitoring and verifying exercise 
intensity and duration for SUP-PA, we hypothesized that this group would engage in 
10 
 the highest amount of MVPA. It was hypothesized that the other groups (UNSUP-PA, 
STEP) may report engaging in similar amounts of MVPA compared the SUP-PA 
group, however, the intensity of this physical activity may not reach the moderate 
threshold reducing total MVPA time. Therefore, the SUP-PA group would have a 
greater increase in cardiorespiratory fitness compared to the STEP and UNSUP-PA 
groups.  
c. Weight loss would differ by group with SUP-PA > UNSUP-PA and SUP-PA > 
STEP across the intervention. 
Rationale: Supervised physical activity programs are considered the gold 
standard. Because an exercise physiologist was monitoring and verifying exercise 
intensity and duration for SUP-PA, we hypothesized that this group would engage in 
the highest amount of MVPA. It was hypothesized that the other groups (UNSUP-PA, 
STEP) may report engaging in similar amounts of MVPA compared the SUP-PA 
group, however, the intensity of this physical activity may not reach the moderate 
threshold reducing total MVPA time. Therefore, the SUP-PA group would have a 
greater energy expenditure and weight loss compared to the STEP and UNSUP-PA 
groups. 
d. Resting blood pressure reductions would differ by group with SUP-PA > 
UNSUP-PA and SUP-PA > STEP. 
Rationale: Supervised physical activity programs are considered the gold 
standard. Because an exercise physiologist was monitoring and verifying exercise 
intensity and duration for SUP-PA, we hypothesized that this group would engage in 
the highest amount of MVPA. It was hypothesized that the other groups (UNSUP-PA, 
11 
 STEP) may report engaging in similar amounts of MVPA compared the SUP-PA 
group, however, the intensity of this physical activity may not reach the moderate 
threshold reducing total MVPA time. MVPA participation reduces resting blood 
pressure in people who are normotensive or hypertensive.45 Therefore, the SUP-PA 
group would have a greater reduction in resting blood pressure compared to the STEP 
and UNSUP-PA groups. 
e. Retention of fat-free mass would differ by group with SUP-PA > UNSUP-PA and 
SUP-PA > STEP across the intervention, and reduction in fat mass, percent body 
fat, and waist circumference would differ by group with SUP-PA > UNSUP-PA 
and SUP-PA > STEP across the intervention. 
Rationale: Supervised physical activity programs are considered the gold 
standard. Because an exercise physiologist was monitoring and verifying exercise 
intensity and duration for SUP-PA, we hypothesized that this group would engage in 
the highest amount of MVPA. It was hypothesized that the other groups (UNSUP-PA, 
STEP) may report engaging in similar amounts of MVPA compared the SUP-PA 
group, however, the intensity of this physical activity may not reach the moderate 
threshold reducing total MVPA time. Because retention of lean mass is associated with 
MVPA participation46 and because increased MVPA would increase energy 
expenditure, we hypothesized that SUP-PA would have a greater retention of fat-free 
mass, reduction in fat mass, reduction in percent body fat, and reduction in waist 
circumference measures compared to the STEP and UNSUP-PA groups. 
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 f. Physical activity self-efficacy across the intervention and perceived self-efficacy to 
continue physical activity following the intervention would differ by group with 
STEP > SUP-PA and UNSUP-PA > SUP-PA. 
Rationale: UNSUP-PA and STEP would provide ample opportunities for 
increasing mastery experiences and self-confidence compared to SUP-PA. Thus, it was 
hypothesized that UNSUP-PA and STEP would have more physical activity self-
efficacy and more perceived self-efficacy to continue physical activity compared to 
SUP-PA. 
g. It was hypothesized that energy intake and eating behaviors would not differ 
between SUP-PA, UNSUP-PA, and STEP. 
Rationale: Because the dietary intervention was identical across the 
intervention groups, it was hypothesized that energy intake and eating behaviors would 
not differ between SUP-PA, UNSUP-PA, and STEP.
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 2.0  REVIEW OF LITERATURE 
2.1 INTRODUCTION 
Overweight and obesity is a major public health concern in the United States.47 Weight loss 
treatment is recommended for all individuals with a BMI over 30 kg/m2 and for individuals with 
a BMI over 25 kg/m2 and weight-related comorbidities.34 Standard behavioral weight loss 
programs (SBWP) have been successful at reducing bodyweight by 8-10%.48,49 However, many 
individuals will eventually regain the initial weight loss due to an inability to adhere to the diet 
and exercise prescription as well as physiological parameters that work against body weight 
reduction.48,50-53 Modest weight losses of about 5% body weight have resulted in significantly 
improved health.54 Moreover, independent of weight loss, regular MVPA can increase 
cardiorespiratory fitness,19,21,22,25-29,36 reduce blood pressure,19,26,28,30 improve body 
composition,25,26,28,31,55 and reduce many other physiological parameters associated with poor 
health. Increased cardiorespiratory fitness is also associated with a reduced risk of heart disease 
and mortality,56-58 which is independent of BMI status.59 Thus, focusing on improving fitness and 
other cardiometabolic parameters through physical activity may be an efficacious strategy to 
reduce the health-risk associated with obesity. 
Clinical research has typically prescribed physical activity in a supervised manner. The 
effects of supervised physical activity programs have been studied extensively. While these 
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 programs are considered the “gold standard,” supervised physical activity may not translate to the 
general public because most individuals do not have access to a free health-fitness facility and 
personal training. An alternative strategy is prescribing physical activity in an unsupervised 
manner. Unsupervised physical activity programs may be more generalizable and representative 
of the “real world.” However, the effects of unsupervised physical activity programs have rarely 
been compared to supervised physical activity programs. Because the effects of unsupervised 
physical activity may offer health benefits, the magnitude of these benefits compared to supervised 
physical activity should be investigated, particularly in an overweight and obese population. 
2.2 OVERWEIGHT AND OBESITY 
2.2.1 Prevalence 
Overweight and obesity are characterized by an excess body weight determined by body 
mass index (BMI). BMI is calculated as weight in kilograms divided by height in meters squared 
(kg/m2).34 Overweight is classified as a BMI of 25.0-29.9 kg/m2 and a BMI of ≥30.0 kg/m2 is 
considered obese.1 It is estimated that 33.9% of US adults are now overweight and 35.1% are 
classified as obese.1 According to data from the National Health and Nutrition Examination Survey 
(NHANES) the prevalence of overweight and obese adults aged 20 years or older has increased 
markedly over the past 30 years.1,2,60,61 It is now estimated that 69.0% of US adults are classified 
as overweight or obese.1 This rapid increase in overweight and obesity has had several negative 
consequences.  
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 2.2.2 Consequences of Obesity 
Obesity is related to several chronic diseases and comorbidities including cardiovascular 
disease,4,62-66 metabolic syndrome,64-67 type II diabetes,64-66,68 kidney disease,64-66,69 gall bladder 
disease,64-66,70 osteoarthritis,66,71,72 sleep apnea,66,73 and some forms of cancer.64-67,74 The risk of 
developing these comorbid conditions is positively associated with an increase in BMI.5 
Subsequently, in 2005 Flegal et al. estimated that obesity was associated with 111,909 excess 
deaths compared to the normal weight category.64 Furthermore, others have estimated that the 
number of annual deaths attributable to obesity is at least 325,000.47 These extensive health 
complications associated with overweight and obesity have led to an economic burden as well.   
The increased rates of overweight and obesity have consequently increased healthcare 
costs. For example, in 1998 the costs of overweight and obesity were approximately $78.5 billion 
with nearly half of this cost being covered by Medicare and Medicaid.75 In 2008, the medical cost 
of obesity nearly doubled as it was estimated to cost $147 billion.6 It was estimated that nearly 
10% of medical spending was spent on obesity-related conditions. On average, overweight and 
obese individuals spent $1,429 more in healthcare costs compared to normal weight individuals.6 
Additionally, Medicare cost $600 more for obese individuals compared to normal weight 
beneficiaries.6 These increased healthcare costs have affected both individuals, the government, as 
well as employers. Obesity-related conditions can affect disability, injuries, absenteeism, and 
healthcare claims.76-78 The rising prevalence rates of overweight and obesity have created many 
unintended consequences, therefore, there is an increased need to identify strategies to help treat 
and limit these health-related conditions. 
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 2.2.3 Factors Affecting the Etiology of Obesity 
In order to properly treat overweight and obesity, it is important to understand the causes 
of the disease. The etiology of overweight and obesity is complex with multiple factors 
contributing to excess weight gain and fat accumulation. Hypotheses relating to the cause of 
obesity include increased energy intake, decreased energy expenditure, environmental factors, 
psychosocial factors, genetic factors, dysregulated endocrinology, as well as many other biological 
factors. These influences are outlined in Figure 2.  
 
 
Figure 2. The Etiology of Overweight and Obesity 
Genetic variables can be one of the predominant drivers in the pathogenesis of obesity; 
additionally, genetic determinants can increase susceptibility to the disease through other pathways 
(e.g. environment, psychosocial, biological, etc.). Genetic variables can influence both energy 
intake and energy expenditure components of the energy balance equation. James V. Neel first 
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 posed the “Thrifty Gene Hypothesis” to explain the rapid rise in type II diabetes; this hypothesis 
states that through natural selection humans have become very efficient at storing fat in times of 
food abundance to prepare for times of famine.79 The U.S. is no longer a hunter-gatherer society, 
with a rich abundance of calorie-dense foods attributing to high levels of energy intake, fat storage, 
and ultimately obesity. Twin studies have also cited that there is a prominent genetic influence on 
BMI and childhood environment has very little influence.80 Similarly, Ravussin et al. found that 
40% of the variance in BMI is related to genetic influences on energy intake/ volitional activity.53 
Therefore, dysregulation of energy balance can be partially explained by genetic predisposition, 
and genetics should not be ignored when considering potential treatment methods for overweight 
and obesity. Behavioral changes such as increasing physical activity may be advantageous for 
individuals predisposed to having a higher BMI. 
In addition to genetic factors, several biological factors may influence individuals towards 
a positive energy balance. These biological factors may be exacerbated by behavioral phenotypes 
promoting body weight gain. Low metabolic rates, leptin levels, low sympathetic nerve activity, 
and low levels of thyroid hormones may all promote weight gain.81-84 These biological factors can 
be influenced by genetics, behavior, and the environment.  
Environmental factors also play a pivotal role in the etiology of obesity. Over the past 
century, the human environment and human behavior have been altered to promote less physical 
activity while concurrently increasing sedentary behavior.85,86 Sedentary behavior is a significant 
contributor to obesity,87-89 type 2 diabetes,87-89 metabolic syndrome,88-90 and cardiovascular 
disease.88,89 Additionally, calorie-dense foods are more available to the consumer. This concurrent 
increase in food availability and decrease in activity are actively contributing to the obesity 
epidemic. 
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 Psychosocial factors such as consumerism, social norms, and cultural norms also have 
impacted and continue to impact the obesity prevalence trend. Eating is not only a form of energy 
intake that is essential for life, but it also has emotional and social influences.91,92 Moreover, 
cultural norms may further promote increased body size.93 African-American women have less 
strict criteria when it comes to perceived body fatness compared to white women.94 Whereas, white 
women are more likely to practice eating restraint and have disordered eating.94 Furthermore, 
males are less likely to be dissatisfied with their bodyweight and females are more likely to want 
to try to lose weight.93 More cultural norms may exist, but further investigation is warranted.  
All of these factors can contribute to the pathogenesis of obesity, making treatment difficult. Most 
treatments are foundationally rooted around the energy balance equation, focusing on strategies 
that ultimately alter either energy intake, energy expenditure, or both. 
2.2.4 Energy Balance 
While the ideology of energy balance is elementary and uncomplicated, energy intake 
equals energy expenditure, there are several dynamics that influence energy intake and energy 
expenditure making energy balance difficult to accomplish. More research is needed to know how 
all of these factors are interrelated and how to best treat obesity. Clearly, obesity treatment focusing 
on reducing body weight needs to be tailored to best treat the factors that are the predominantly 
driving the weight gain. These factors and treatment may vary by individual. Obesity and excess 
body weight has several health consequences that can be improved with weight loss, however, 
long-term weight loss has been difficult for some people to achieve.48,50,51,53 Physical activity may 
be a potential treatment strategy for overweight and obese populations. Increasing physical activity 
is a common strategy to help promote a negative energy balance, and is commonly prescribed in 
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 weight loss programs.48,49 However, physical activity is rarely the sole focus of these programs; 
most programs focus on weight loss instead. Physical activity helps reduce body weight, 14,32,33 
promote weight loss maintenance,14 and helps attenuate the complications associated with obesity 
independent of weight loss.95 Moreover, physical activity can be achieved by most individuals 
regardless of the pathology of the individuals’ obesity. 
Energy balance is a result of energy intake being equivalent to energy expenditure. When 
these two conditions are in congruence, known as homeostasis, weight was maintained (Figure 3). 
Weight gain is a result of energy intake exceeding the amount of energy expenditure. Conversely, 
weight loss is a result of energy expenditure exceeding the amount of energy intake.  
 
 
Figure 3. Energy Balance Diagram 
2.3 EFFECTS OF BEHAVIORAL WEIGHT LOSS INTERVENTIONS 
Standard behavioral weight loss programs (SBWP) are typically recommended as the first 
line of treatment against overweight and obesity. Organizations such as the National Heart Lung 
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 and Blood Institute, The American Heart Association, and The American College of Sports 
Medicine recommend behavioral treatment as a treatment strategy.13,34,96 SBWP incorporate 
strategies to reduce dietary intake, increase physical activity and change other behaviors that may 
be contributing to weight gain. SBWP are typically based on behavior theories that include but are 
not limited to Social Cognitive Theory, Transtheoretical Model, Theory of Planned Behavior.91 
These theory-based SBWP approaches typically induce weight loss of 8-10% within 6 months,48,49 
with long-term weight loss being more variable. 
 SBWP are commonly delivered in a group-based format. A trained behavioral 
interventionist leads the group session, and each session has an educational and behavior change 
component. Integrated within these lessons are behavioral constructs that include, but are not 
limited to, goal setting, problem solving, cognitive restructuring, self monitoring, relapse 
prevention, and others.91 These group intervention sessions also offer the participants an 
opportunity for social support. 
2.3.1 Dietary Modification 
Dietary modification and calorie restriction are key components of SBWP. General 
recommendations for weight loss include daily calorie goals of 1200-1800 calories depending on 
body weight. Additionally, fat intake is recommended at levels of 20-30% of total intake.97 Most 
SBWP provide flexible dietary modifications to promote weight loss, self-efficacy, and long-term 
behavior change. However, other types of dietary modification have been successful for inducing 
weight loss. 
Very Low Calorie Diets (VLCD) have been successful at inducing large weight losses.91,98 
VLCD’s offer very regimented diets, meal replacements, or other food provisions which minimize 
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 the individual’s choice. Typical VLCD’s prescribe up to 800 calories per day.91,98 Studies utilizing 
VLCD’s promote weight  losses of  approximately 20% of initial body weight in the first 12-16 
weeks, however, these strategies may be difficult to sustain.91,98 At one year of follow-up weight 
loss with VLCD’s are similar to less stringent diets.99 
 The use of meal replacements is another dietary strategy used within weight loss 
interventions.  Studies using this strategy have shown the efficacy of this strategy.100,101 Clearly, 
dietary modification is an integral part of weight management regardless of the prescription. 
2.3.2 Physical Activity 
Physical activity is defined as any bodily movement produced by skeletal muscle that 
results in energy expenditure. The current public health recommendations suggest that all U.S. 
adults engage in 150 minutes of moderate intensity, 3.0-5.9 metabolic equivalents (METS), or 75 
minutes of vigorous physical activity, ≥6.0 METS, or an equivalent combination of both per week 
done on most if not all days of the week and completed in bouts of ≥10 minutes. Moderate physical 
activity is equivalent to brisk walking at 3 to 4 mph.102 Vigorous physical activity is equivalent to 
jogging at 4 to 5 mph or faster.102 All U.S. adults are encouraged to participate in regular MVPA, 
however, only 5% of the population is meeting the recommended amounts.12 
Increased body weight and obesity increases the risk of cardiovascular disease,4,5,62-66 type 
II diabetes,5,65,66,68 and mortality.103,104 However, MVPA and cardiorespiratory fitness are 
associated with reduced risk of cardiovascular disease, type II diabetes, and mortality.56-58,105-107 
Therefore, overweight and obese individuals should be encouraged to engage in regular MVPA.  
Because physical activity is the most variable and modifiable component of the energy 
balance equation, equating for 10-30% of total daily energy expenditure,108 it may be efficacious 
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 to focus on this behavior in an overweight and obese population seeking weight loss. Physical 
activity alone has promoted minimal weight losses in men and women.27,32,33 Wing reported that 
men and women lost about 1-2 kg. in weight loss interventions due to exercise alone,33 and a meta-
analysis done by Miller and colleagues reported that exercise alone contributed to a mean weight 
loss of 2.9 kg.32 Given that physical activity alone only produces modest weight losses, most 
behavioral strategies for weight loss focus on increasing energy expenditure through physical 
activity in combination with decreasing energy intake. Studies have shown that adding physical 
activity to an energy reduced diet increases weight loss compared to what is achieved through diet 
alone.14,32,33 Moreover, the American College of Sports Medicine (ACSM) recommends physical 
activity as an important lifestyle component to promote long-term weight loss and to prevention 
weight regain.13,14 
2.4 PHYSIOLOGICAL RESPONSES TO PHYSICAL ACTIVITY 
The body’s physiological responses to aerobic physical activity primarily occur in the 
musculoskeletal, cardiovascular, respiratory, endocrine, and immune systems, but activity also 
impacts other systems in the body. The physiological stress of activity overloads the body’s 
systems leading to adaptations which increase the body’s efficiency at handling the activity 
stimulus. These adaptations lead to improved muscular strength, cardiorespiratory fitness, 
cardiometabolic health, body composition, and many other downstream effects.109,110 
Understanding the body’s response to physical activity is important when evaluating the effects of 
physical activity on overall health.   
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 Maximal oxygen consumption is commonly measured as an indicator of cardiorespiratory 
fitness.109 Maximal graded exercise tests start at a relatively low workload which increases 
progressively during the test. The exercise test continued until participant exhaustion. These types 
of tests are excellent indicators of cardiorespiratory fitness.109 Similarly, submaximal exercise tests 
can be used to predict maximal oxygen consumption while limiting the risk of the exercise. In a 
typical submaximal test, the workload will progress until a designated stopping point (e.g., 85% 
age-predicted maximal heart rate). The investigators can then predict maximal oxygen uptake or 
use the value at test termination as a relative marker of cardiorespiratory fitness.109 When 
evaluating the effects of a physical activity intervention, cardiorespiratory fitness is one of the 
most common outcomes. Cardiorespiratory fitness is associated with a decreased risk of 
cardiovascular disease and mortality, 56-58,105 and it is used as a surrogate measure of the body’s 
physiological changes due to physical activity. It is important to understand the physiological 
changes that are represented when evaluating changes in cardiorespiratory fitness due to physical 
activity participation.  
The cardiovascular and the respiratory systems work together and their primary functions 
are to provide the body with oxygen and nutrients while also removing carbon dioxide, removing 
metabolic waste products, promoting body temperature regulation, promoting acid-base 
regulation, and transporting hormones.111 Physical activity places a higher demand on these 
systems, making them work faster and more efficiently. When the activity is of a higher intensity 
or longer duration, a greater burden is placed on these systems leading to more prominent 
adaptions. However, even small increases in physical activity at relatively modest intensities can 
produce physiological adaptations.25 
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 Many cardiovascular adaptations to physical activity are well understood. Cardiac output 
is a function of stroke volume and heart rate. Cardiac output acutely increases in response to 
physical activity to match the oxygen demand in the skeletal muscle.109 Regular MVPA leads to 
physiological adaptations increasing the capacity of cardiac output. After aerobic training, stroke 
volume is increased at rest, during submaximal exercise, and during maximal exercise, thus, heart 
rate is decreased at rest and during submaximal exercise in order to match the change in stroke 
volume. The increase in stroke volume is due to increases in left ventricular size, myocardial 
contractility, plasma volume, increased end-diastolic volume, and decreased total peripheral 
resistance.109,110 The increase in end-diastolic volume can largely be explained by the increased 
volume of blood, increased return of blood to the ventricle, and increased ventricular dilation or 
stretching.109,110 Other structural changes in the heart, including hypertrophy of cardiac muscle, 
allow greater force to be exerted during each heartbeat, emptying more blood from the left 
ventricle. The carrying capacity of the blood is also increased due to increased hemoglobin. 
Regular MVPA also induces changes in the skeletal muscle to enhance the efficiency of oxygen 
delivery to the working muscle. Capillary density is increased resulting in a greater capacity for 
blood flow and more time to exchange gases, substrates, and metabolites; this also decreases total 
peripheral resistance allowing the left ventricle to disperse more blood because there is less 
resistance in the arteries.109,110 Additionally increased mitochondrial size and density increases the 
working muscles’ efficiency at removing and utilizing oxygen. Oxygen extraction or arteriovenous 
oxygen difference (a-vO2) is increased allowing the working muscle to work efficiently and longer 
until fatigue.109 Furthermore, oxidative enzyme activity increases with aerobic training, and 
myoglobin content is decreased promoting oxygen storage in muscle fibers.109 The sum of all these 
adaptations greatly enhances the oxidative capacity of the aerobically-trained muscle.  
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 The respiratory system also responds acutely to physical activity leading to chronic 
adaptations. Pulmonary ventilation increases in response to physical activity through respiratory 
centers in the motor cortex and through proprioceptor feedback. During higher intensity activity 
increases in carbon dioxide production, hydrogen ions, and body temperature promote ventilation. 
Chronic respiratory adaptations to activity include increases in tidal volume, respiration rate, and 
pulmonary diffusion.109,110 As the body becomes more efficient at utilizing oxygen, less ventilation 
is needed and the ventilatory rate decreases at rest and during submaximal exercise. In sum, these 
cardiovascular and respiratory physiological adaptations to aerobic exercise are the primary drivers 
when improving cardiorespiratory fitness, which is known to have lasting health benefits. Because 
obesity is related to poor cardiorespiratory fitness and cardiovascular disease it is important to note 
the potential benefits of physical activity on the cardiovascular and respiratory systems. 
Another clinical measure that is evaluated during physical activity trials is blood pressure. 
Blood pressure is typically defined as the force exerted on the walls of blood vessels, specifically 
arteries, during cardiac systole and diastole.  Blood pressure is related to both cardiovascular and 
metabolic health outcomes. Several studies have looked at the effect of physical activity on blood 
pressure in different populations.25,45,112 In a review conducted by Whelton et al., the authors 
concluded that aerobic exercise caused a reductions in systolic blood pressure of 3.84 mmHg and 
reductions in diastolic blood pressure of 2.58 mmHg.45 However, specific trials have found that 
aerobic exercise may not improve blood pressure in certain populations.25,26  Understanding how 
physical activity impacts blood pressure has important clinical implications that may inform future 
activity prescriptions.   
Physical activity acutely affects bloods pressure, and habitual physical activity can help to 
reduce blood pressure. During a session of MVPA systolic blood pressure rises linearly with work. 
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 This increase in systolic blood pressure can largely be attributed to increases in cardiac output 
without an equivalent decrease in total peripheral resistance. This response is normal as the 
increased systolic blood pressure is needed to prevent hypotension during intense physical activity. 
Following a session of MVPA blood pressure drops below pre-exercise resting levels; this is 
known as post-exercise hypotension. Although the mechanisms of post-exercise hypotension are 
not completely understood several pathways may be involved. During exercise the baroreceptor 
reflex is “reset” to a higher point and sympathetic activity is increased.109,110 Following exercise 
these arterial baroreflexes and cardiopulmonary receptor reflexes reset to a lower pressure, thus, 
sympathetic innervation is lower than pre-exercising levels.113-115 There is evidence to suggest that 
the body is less reactive to catecholamines following a bout of exercise, but some of these 
mechanisms are unknown.115 Additionally, it is hypothesized that vascular responses to α-
adrenergic receptor stimulation is impaired reducing sympathetic nerve activity.115 During 
exercise, increases in blood flow, cyclic wall stress, pulsatile blood flow, and catecholamines 
stimulate the release of nitric oxide, a vasodilator, reducing blood pressure.115 Nitric oxide blunts 
α-adrenergic receptor stimulation reducing vasoconstriction.115 Tanaka et al. also hypothesize that 
the increased pulse pressures and distension of the arteries during exercise may lead to the 
stretching of the collagen fibers, modifying cross-linking and ultimately increasing arterial 
compliance over time.116 Some physiological mechanisms of blood pressure change remain 
unknown and should be investigated further.  
Another physiological benefit of physical activity is weight loss. Aerobic physical activity 
alone produces a mean weight loss of about 2-3 kg.27,32,33 however, physical activity can encourage 
positive body composition changes (e.g., increased skeletal muscle, decreased abdominal fat, etc.) 
independent of body weight change. This change in abdominal fat is important to recognize 
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 because abdominal obesity, specifically excess visceral fat has been linked to metabolic and 
cardiovascular health.63,117-119 Using waist circumference (WC) measures and waist to hip ratios 
(WHR) as surrogate measure, studies have shown abdominal fat is related to metabolic risk,120 
cardiovascular risk,121 and mortality.120,121 Numerous cross-sectional studies have shown evidence 
that physical activity is inversely related to WC and WHR.122,123 Additionally, randomized 
controlled trials have confirmed that increasing physical activity can help to reduce WC, WHR, 
and abdominal fat mass without a consequent change in body weight.28,124 Because visceral fat is 
a predictor of dyslipidemia, glucose tolerance, insulin resistance, systemic inflammation, 
hypertension, cardiovascular disease, type II diabetes, and all-cause mortality,117,125 it is reasonable 
to focus on reducing abdominal fat through physical activity rather than focusing specifically on 
weight loss. Understanding how physical activity influences abdominal fat is important.  
Abdominal fat is comprised of both visceral fat and subcutaneous fat with most of the 
evidence suggesting that visceral fat is closely related to metabolic dysfunction leading to 
increased risk of diabetes and cardiovascular disease. Physical activity puts stress on the body to 
produce energy in order for the body to continue to move. During aerobic physical activity, 
glycogen is mobilized from the liver, working muscles absorb glucose from the blood, muscle 
glycogen is broken down and utilized via glycolysis, and intramuscular triglycerides are used for 
energy.109,110 Additionally, lipolysis increases stimulating the release of free fatty acids from 
adipose tissue.109,110 These free fatty acids go through beta oxidation converting them to acetyl 
coA which in turn produces ATP through the Krebs cycle, which is then utilized as an energy 
source.109,110 It is hypothesized that free-fatty acid mobilization is one of the primary reasons 
abdominal fat is decreased with regular MVPA.  
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 All of these physiological adaptations are important to understand when considering the effects of 
different physical activity prescriptions. These physiological responses may vary by exercise 
intensity, duration, and frequency. Being able to closely monitor the full spectrum of physical 
activity participation during a physical activity intervention may help explain some of the 
physiological changes that are occurring. 
2.5 THE PHYSICAL ACTIVITY SPECTRUM AND HEALTH 
2.5.1 Health Impact of Sedentary Behavior 
Sedentary behavior is typically defined as any waking activity characterized by ≤1.5 
metabolic equivalents (METs) done in a sitting or reclining posture.126 Epidemiological studies 
using television viewing time as measurement of sedentary time have linked sedentary behavior 
to several negative health outcomes.87,127-129 In 2003, Hu et al. found that sedentary behavior was 
associated with a higher risk of becoming obese and developing type II diabetes.87 Furthermore, 
Warren et al. found that increased levels sedentary behavior were associated with a higher rate of 
cardiovascular mortality in men.129 Therefore reducing sedentary behavior may be efficacious for 
overall health.  
 There have been relatively few studies focusing on strategies and the long-term effects of 
changing sedentary behavior. Reducing sedentary behavior by increasing energy expenditure 
through postural changes or increasing activity are potential strategies that need to be explored. 
Standing increases energy expenditure by about 9 kcal/hour compared to sitting.130,131 
Additionally, short bouts of walking have significantly increased energy expenditure compared to 
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 sitting alone.132,133 However, the effects of increased participation in MVPA on sedentary behavior 
are not completely understood. Since sedentary behavior can adversely affect health independent 
of MVPA participation, further investigation is warranted.127,134,135 Therefore activity 
interventions may want to focus on the total activity pattern (e.g. sedentary, light, MVPA) rather 
than simply focusing on MVPA. Strategies to increase MVPA while reducing sedentary behavior 
need to be investigated. 
2.5.2 Health Impact of Light Intensity Physical Activity 
Light intensity physical activity is defined as any activity producing energy expenditure at 
1.5 to <3.0 METs. This includes slow walking, activities of daily living, and some forms of 
occupational-related activity. Light physical activity is not considered in the public health 
recommendations for physical activity, yet, light activity may be important for overall health. 
Lee and Paffenbarger reported that light physical activity was not associated with a reduced risk 
of mortality but moderate and vigorous physical activity were.136 However, these data were 
collected via self-report questionnaire and only the intensity of sport, fitness, and recreational 
activities were measured and used in the analysis. Light physical activity is commonly 
accumulated throughout the day and may not be as prominent in sport and fitness activities. Thus, 
these results should be interpreted carefully. Because light physical activity is accumulated 
throughout the day, it may be difficult to capture in a self-report questionnaire. Measuring light 
physical activity with objective physical activity monitors may be a more valid and reliable 
technique. Recent studies have shown that light physical activity is associated with health benefits 
when the activity is measured objectively.137-141 Jakicic et al. reported individuals reducing the 
most body weight in a diet and exercise intervention also engaged in the highest levels of light 
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 physical activity.137 Healy and colleagues found that light physical activity is independently 
associated with 2 hour glucose.138 Moreover, several studies have found that light physical activity 
is associated with lower BMI, reduced waist circumference, reduced inflammation, and increased 
insulin sensitivity.139-141 Light physical activity may not stimulate the cardiovascular and 
respiratory systems enough to see significant changes in cardiorespiratory fitness, however, these 
other health benefits suggest that light physical activity is important for overall health. 
2.5.3 Health Impact of Moderate-to-Vigorous Physical Activity 
Moderate to vigorous physical activity (MVPA) is typically defined as any activity 
producing energy expenditure of ≥3.0 METs. MVPA is the most commonly studied form of 
physical activity and most public health recommendations focus on this threshold of activity 
because it is attainable and offers significant health benefits.  
Most physical activity programs focus on increasing MVPA in the form of brisk 
walking.142 Walking is the most common form of physical activity making it a reasonable target 
for increasing MVPA.142,143 It is hypothesized that focusing on walking improves adherence to the 
MVPA prescriptions since opportunities to walk are plentiful. However, physical activity 
programs that have focused on other forms of activity (e.g., running, bicycling, swimming, sports, 
etc.) have been successful at increasing MVPA.144,145 Individuals may have different preferences 
for physical activity and should be encouraged to engage in whichever activity is most enjoyable 
as long as the stimulus is enough to elicit health benefits. As stated previously, a proper stimulus 
should overload the systems of the body enough to encourage physiological adaptions increasing 
capacity and efficiency. Regular MVPA is associated with reduced risk of mortality, 56-58,146 
cardiovascular disease, 56-58,146-148 type II diabetes,107,149-151 hypertension,152-154 psychological 
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 issues,155,156 and some forms of cancer.157,158 Similarly low levels of physical activity and low 
cardiorespiratory fitness have been linked to increased rates of all-cause mortality.58,146 Low 
physical activity, low energy expenditure, and low fitness are also associated with excess body 
weight.159,160 Thus, it is reasonable to prescribe overweight and obese individuals to increase 
MVPA for energy expenditure and cardiorespiratory benefits.  
Randomized-controlled trials have demonstrated that increasing MVPA will acutely 
promote physiological adaptations. These adaptations have persisted in longer trials eliciting 
health benefits such as reduced waist circumference,28,124,161 increased insulin sensitivity,124 
reduced blood pressure,42,45,113 reduced prevalence of depression,162 improved lipid profiles,163,164 
and increased cardiorespiratory fitness.19,21,22,25,26,28,29,36,55 Randomized-controlled trials focusing 
on increasing MVPA have been successful at increasing MVPA levels whether the activity was 
supervised or unsupervised.19,21,22,25,26,28,29,36,55 Participation rates in MVPA are still not as high as 
desired in these trials, however, participation is enough to elicit health benefits. In 2007, Church 
et al. found that relatively small increases in MVPA (72.2 ± 12.3 min/wk at 50% of peak maximal 
oxygen consumption) were sufficient to improve cardiorespiratory fitness by 4.2% over 6 
months.25 Participating in MVPA for a longer duration produced even more significant increases 
in cardiorespiratory fitness.25 Moreover, Donnelly et al. found that participating in 2000 kcal/wk 
of supervised physical activity for 16 months improved cardiovascular fitness by 20% in males 
and 16% females.27 In this trial, men also had significant reductions in body weight (5.2 ± 4.7 kg) 
total fat (73.9 ± 68.9 cm2), visceral fat (22.5 ± 21.4 cm2), and subcutaneous fat (51.4 ± 54.4 cm2).27 
Similarly, Ross et al. found that 3 months of exercise training at 77% of maximal heart rate was 
sufficient to increase cardiorespiratory fitness by 16% and also decrease abdominal fat in obese 
men without a change in total body weight.28  
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 Interventions focusing on increasing MVPA have been successful in the past. These 
changes in MVPA have elicited multiple health benefits. These trials have utilized either 
supervised or unsupervised physical activity, however, few studies have directly compared these 
two types of activity programs. Moreover, past studies have mostly focused on changes in MVPA 
and have not measured the simultaneous changes in sedentary behavior and light physical activity. 
Future studies should focus on the entire physical activity spectrum to better understand the 
physiological benefits associated with changes in physical activity.  
2.6 COMPENSATORY CHANGES IN PHYSICAL ACTIVITY 
Most public health initiatives have focused on increasing MVPA for health benefits, 
however, sedentary behavior and light physical activity are important contributors to health. 
Changing MVPA may positively or negatively influence sedentary behavior and light physical 
activity. The ActivityStat hypothesis states that increasing activity in one domain will lead to a 
compensatory change in activity in another domain in order to maintain overall energy expenditure 
levels over time.35 This hypothesis is foundationally built upon total activity being homeostatic, 
thus increasing MVPA leads to an increase in sedentary behavior or a decrease in light physical 
activity. This is a relatively novel hypothesis and studies have recently begun to investigate total 
activity patterns. A systematic review of this hypotheses found that results are still mixed and 
methodological approaches are needed to test overall activity patterns and the compensation effect 
of activity interventions.35 In the systematic review, 12 out of the 28 studies found clear evidence 
of physical activity compensation; another 3 studies had mixed results, while the remaining 13 
studies found no compensation effect.35 While there is conflicting evidence whether the 
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 ActivityStat hypothesis is substantiated, further investigation into total activity patterns is needed, 
particularly in supervised exercise trials.   
2.7 TYPES OF PHYSICAL ACTIVITY PROGRAMS 
2.7.1 Supervised and Unsupervised Physical Activity Programs 
Comparisons of supervised physical activity programs versus unsupervised physical 
activity programs in numerous populations have been previously studied.19,21-24,26,29,36,37,165-167 In a 
systematic review, Dalal et al. reported that unsupervised and supervised cardiac rehabilitation 
programs have similar effects on improving clinical and health-related quality of life outcomes.165 
Similarly, Ashworth et al. compared supervised physical activity versus unsupervised physical 
activity programs in older adults finding that supervised physical activity programs were superior 
to unsupervised programs in the treatment of peripheral vascular disease (PVD), both physical 
activity programs were successful at improving outcomes in patients with chronic obstructive 
pulmonary disease (COPD), and unsupervised physical activity programs were superior in terms 
of long-term adherence to physical activity.166 However, physical activity adherence was measured 
by self-report in all of these studies, which is a major limitation to the study results.29,166 Dunn et 
al. compared the effects of supervised physical activity and lifestyle (unsupervised) physical 
activity finding that the supervised physical activity induced greater fitness benefits at 6 months 
despite physical activity increasing similarly.36 At month 24, the supervised physical activity and 
lifestyle physical activity groups had equal improvements in physical activity, fitness, and blood 
pressure.19 Again, physical activity was self-reported which is a major limitation. Furthermore, 
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 this trial was not done in an overweight and obese population, so it is unclear if these results are 
translatable to this population.   
Previously, several studies have evaluated the effects of supervised and unsupervised 
programs in a population of overweight and obese adults. Craighead and Blum evaluated the 
effects supervised physical activity compared to physical activity contracting (i.e., signing a 
written contract to participate in physical activity) and minimal-contact physical activity 
contracting within the scope of standard behavioral weight loss program (SBWP) concluding that 
the supervised physical activity group had the most weight loss and greatest improvement in 
cardiorespiratory fitness.23 In this study, the supervised exercise group met three times per week 
and participants were required to keep their heart rate up (75-80% of maximum) for about 20 
minutes. Two days a week the participants participated in a walk-jog program and the other day 
participants were encouraged to do calisthenics. The physical activity contracting group and 
minimal contact group signed a contract to participate in about 90 minutes of exercise per week.  
No formal analyses were conducted to look at physical activity type, dose, or adherence, therefore, 
it is difficult to interpret the effects of the physical activity prescriptions.  
Contrarily, Perri et al. found that unsupervised physical activity was superior to supervised, 
group-based physical activity in terms of physical activity participation, adherence, and weight 
loss outcomes after 1 year of weight loss treatment.22 The supervised and unsupervised physical 
activity groups were prescribed 60-70% maximal heart rate, 30 min/day, 5 days/wk of walking. 
Both groups were also prescribed the same low-fat diet of 1,200 kcal/day. During the first 6 
months, the group-based, supervised physical activity group was encouraged to get 3 days/week 
of supervised group exercise and supplement that with 2 days of walking on their own. During the 
second 6 months, the supervised physical activity group was encouraged to engage in 2 days of 
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 supervised group exercise and supplement that with 2 days of walking on their own. The 
unsupervised group was encouraged to get all of their activity in an unsupervised manner. After 6 
months, the supervised and unsupervised groups were participating in the same amounts of 
physical activity (104.4 ± 39.5 and 104.0 ± 25.5 respectively). After 1 year the supervised physical 
activity group was engaging in less physical activity (45.4 ± 30.5) compared to the unsupervised 
group (66.2 ± 21.6). Both groups increased cardiorespiratory fitness similarly during the first 6 
months, and these improvements were maintained through month 12. The unsupervised group self-
reported better adherence to the physical activity protocol, but this could not be confirmed by the 
investigators. Also, the intensity of the physical activity was not evaluated.   
Unsupervised lifestyle activity also had better weight maintenance outcomes after one year 
of follow-up in trial conducted by Andersen et al.21 In this trial, participants in the supervised 
physical activity group were prescribed 16 weeks of supervised step aerobics for 45 min/day 3 
days/wk. It was estimated participants expended 450-500 kcals per exercise session. After the 
initial 16 weeks of exercise training, the participants were given videotapes of the step classes for 
continued home use. The lifestyle activity group was encouraged to increase moderate-intensity 
physical activity by 30 minutes per day on most days of the week. During the initial 16 weeks, 
participants were given a 3-dimensional accelerometer to help self-monitor physical activity. Both 
groups received the same 1,200 kcal/day dietary prescription during the initial 16 weeks. After the 
first 16 weeks both groups lost weight, decreased body fat,  improved cardiorespiratory fitness, 
decreased blood pressure, decreased cholesterol, and decreased triglycerides similarly.21 After the 
16 week intervention, participants were followed for one year. Participants in the supervised 
exercise group regained 1.6 kg compared to a 0.08 kg in the lifestyle group. Additionally the 
36 
 lifestyle group was able to maintain cardiorespiratory fitness levels, while the supervised group 
decreased fitness significantly.   
In a trial to prevent weight gain in men, Leermakers et al. compared a clinic-based 
(supervised) and a home-based (unsupervised) behavioral weight management intervention that 
focused on increasing physical activity and decreasing fat intake.24 The clinic-based group 
attended weekly meetings during the first 8 weeks, followed by 8 weeks of meeting every other 
week. These meetings included a 30 minute lesson on nutrition or exercise followed by a 
supervised exercise session. Participants were encouraged to supplement the supervised exercise 
session with at least three more days of exercise per week on their own. The home-based group 
had one group educational session on exercise safety followed by weekly newsletters to deliver 
intervention material. After the initial 8 weeks, newsletters were sent every other week to match 
the clinic-based group. Participants were encouraged to engage in at least 4 days of unsupervised 
physical activity on their own, and received telephone calls on a weekly or biweekly basis from 
study staff to provide feedback and assist with goal setting. The exercise program for both groups 
consisted of walking or jogging at least 4 days/week progressing up to 3 miles/day. Participants 
were encouraged to exercise at 60-70% of maximal heart rate reserve. All participants were given 
a pedometer to track total steps, and all participants were encouraged to self-monitor activity. Both 
groups were also instructed to reduce fat intake to 20% of total caloric intake; other dietary 
recommendations were similar for both groups. Following 4 months of treatment, there were no 
differences in weight change, body composition, change in fitness, or physical activity.24  
However, more participants self-monitored in the clinic-based group and the clinic-based group 
had more individuals achieving the physical activity goal of 120 miles completed (48% vs. 20.8%).  
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 Based upon these studies, it is difficult to discern whether supervised or unsupervised physical 
activity programs promote better physical activity participation and health outcomes. These studies 
focused on the effects of different physical activity programs on weight loss, however, weight can 
be affected by much more than just the physical activity program. Moreover, the aforementioned 
studies lacked the measurement techniques and study design to properly compare the effects of 
supervised and unsupervised physical activity programs on physical activity participation. When 
studying the effects of varying physical activity programs in an overweight and obese population, 
physical activity should be prescribed in identical doses, and physical activity should be measured 
objectively to limit any potential reporting bias. Additionally, when studying the effects of physical 
activity, it is important to evaluate the participants’ activity outside of the physical activity 
sessions. Sedentary behavior as well as all forms of physical activity spectrum (light, moderate, 
vigorous) can influence health outcomes.137,141,168-171 Because of the possibility of compensation35 
(decreasing physical activity in one domain due to an increase in physical activity in another 
domain), measuring the total activity pattern is critically important when evaluating the effects of 
physical activity. No study to date has objectively measured physical activity or evaluated total 
activity patterns when comparing supervised and unsupervised physical activity programs. 
2.7.2 Steps per Day Programs 
Walking is the most common form of physical activity and many public health initiatives 
have focused on increasing physical activity through walking.142,143 Many of these initiatives have 
utilized pedometers to help with self-monitoring and motivation. Most trials have focused on a 
total step goal of 10,000 steps/day. This recommendation was based off a study conducted by 
Yamanouchi et al., which recommended a 10,000 steps/day goal to promote glucose control in 
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 patients with type II diabetes.40 By the end of the study, participants took an average of 19,200 ± 
2,100 steps/day and improved their metabolic profile.40 A recent review found that studies utilizing 
steps/day recommendations and pedometers have been successful at increasing step counts by 
2,000-2,500 steps/day.172 Because steps/day recommendations have been a successful intervention 
strategy, researchers have begun to focus on the clinical implications of these increases.  
Steps/day is negatively associated with BMI.173 Thus, increasing steps/day may be a 
positive strategy to increase activity and promote weight loss. Schneider et al. found that 
promoting 10,000 steps/day during a 36 week trial promoted a 4.5 kg. mean weight loss in 
individuals adherent to the prescription with no reported changes in dietary intake.41 Other studies 
have noted that a 10,000 step/day recommendation has promoted positive changes in body 
composition, glucose control, lipid profiles, and blood pressure.26,39,41,43,44,174 Steps/day 
recommendations do not focus on intensity of activity and no study has investigated the activity 
patterns of individuals adhering to this type of activity prescription. Because steps/day 
recommendations do not offer an intensity recommendation, the stimulus may not be enough to 
encourage changes in cardiorespiratory fitness. A few studies have found modest improvements 
in fitness in sedentary adults, however, most recently, Bell et al. found that the 10,000 steps/day 
recommendation did not change fitness.26 Promoting brisk walking (equivalent to moderate 
intensity physical activity) for 25% of the total step count may be necessary to produce fitness 
benefits. However, this recommendation has not been investigated.  
 Utilizing pedometers and step counts has been a successful intervention strategy for 
previously sedentary adults. Using a recommendation of 10,000 steps/day has elicited health 
benefits. However, encouraging individuals to increase the intensity of some of their total steps 
may also be an efficacious strategy for increasing fitness. Additionally, little is known about the 
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 total activity pattern of individuals who are adhering to the 10,000 steps/day recommendation. 
Investigating the sedentary behavior, light activity, and MVPA of individuals who are adherent to 
the 10,000 steps/day prescription may help explain the health benefits of this recommendation. 
2.8 SUMMARY 
Overweight and obesity continues to be a significant public health concern. Behavioral 
treatment to alter physical activity and diet is one of the first intervention strategies to help reduce 
bodyweight and the consequences associated with excess weight. Physical activity alone has health 
benefits independent of weight change. Typically, physical activity is prescribed in a supervised 
or unsupervised manner. Supervised physical activity has been typically utilized in clinical 
research settings, but results from supervised physical activity programs may not be generalizable 
to “real world” settings. Unsupervised physical activity programs may be more generalizable, 
however, it is difficult to confirm adherence to the physical activity prescription. Using objective 
physical activity monitors may help investigators to confirm adherence to the prescription, while 
also allowing investigators to examine participants’ participation in other forms of physical 
activity. To our knowledge, no study has examined physical activity adherence, physical activity 
compensation, and the physiological effects of a supervised and unsupervised physical activity 
program of the same prescribed dose. Furthermore, no study has investigated the efficacy of novel 
step/day program compared to a supervised physical activity program. Therefore, the primary aims 
of this study were to examine the effects an unsupervised physical activity program prescribed in 
minutes/week, an unsupervised physical activity program prescribed in steps/day, and a supervised 
40 
 physical activity program prescribed in minutes/week on MVPA participation, compensatory 
changes in physical activity, cardiorespiratory fitness, weight, and body composition.
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 3.0  METHODS AND EXPERIMENTAL DESIGN 
3.1 SUBJECTS 
Fifty-two apparently healthy overweight and obese (BMI 25.0 to <40.0 kg/m2) adults 
between the ages of 18-55 years old were enrolled in this study at the University of Pittsburgh 
Physical Activity and Weight Management Research Center. Table 1 contains a complete list of 
all inclusion and exclusion criteria. 
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 Table 1. Study Eligibility Requirements 
Inclusion Criteria 
• Male or Female 
• Aged 18-55 years old 
• BMI of 25.0 to <40.0 kg/m2 
• Ability to provide informed consent 
• Ability to provide physician’s clearance to participate in a weight loss intervention 
Exclusion Criteria 
• Engaging in >60 min/wk (accumulated in bouts of ≥10 minutes) of moderate-to-vigorous physical activity 
over the past month 
• Presence of contraindications to physical activity as identified on a physical activity readiness questionnaire 
(PAR-Q) 
• History of metabolic, cardiac, or pulmonary disease that classifies the individual as high risk by the 
American College of Sports Medicine (e.g., coronary heart disease, diabetes mellitus, uncontrolled 
hypertension, etc.) 
• History of myocardial infarction, coronary bypass surgery, angioplasty, or other cardiovascular- related 
surgeries 
• Taking medication that may affect heart rate or blood pressure responses to physical activity 
• Resting systolic blood pressure ≥150mmHg or diastolic blood pressure ≥100mmHg 
• Medication that may affect body weight/metabolism (e.g., synthroid) 
• Current or previous participation in a physical activity or weight management research project in the past 6 
months 
• Weight loss of ≥5% or 15 pounds total of current body weight in the previous 6 months 
• Currently being treated for an eating disorder (e.g., anorexia, bulimia, etc.) 
• Previously undergone bariatric surgery (e.g., lap-band, gastric bypass, etc.) 
• For women, those currently pregnant, pregnant during the previous 6 months, or plan on becoming pregnant 
in the next 6 months 
• Currently being treated for any psychological issues or problems, taking any psychotropic medications, or 
receiving treatment with psychotropic medications within the previous 6 months 
• Being out of town during for an extended amount of time during the weight loss intervention which may 
affect participation in the study 
• Currently using a physical activity monitor to track activity (e.g., Jawbone UP, Fitbit, etc.) 
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 3.2 RECRUITMENT AND SCREENING PROCEDURES 
Subjects were recruited from the University of Pittsburgh Obesity and Nutrition Research 
Participant Registry, the University of Pittsburgh Clinical and Transitional Science Institute, and 
through an announcement from the University of Pittsburgh Read Green Email System. Potential 
subjects were instructed to call University of Pittsburgh Physical Activity and Weight 
Management Research Center (PAWMRC) where trained staff conducted a telephone screening 
to determine eligibility. The telephone screening included a detailed description of the study and 
its potential risks and benefits. Upon the potential subjects’ verbal consent, trained staff began the 
initial telephone screen to determine eligibility.  The telephone screen contained questions about 
medical history and other pertinent questions related to the inclusion/exclusion criteria. A copy of 
the telephone screening form can be seen in Appendix B. If the potential subject was ineligible 
based upon a telephone screening question, the telephone screen was stopped immediately and the 
study staff did not ask any more personal questions. Once the telephone screen was completed, 
study staff was instructed to obtain the potential subjects’ contact information. The Principal 
Investigator reviewed all telephone screening forms before inviting anyone to the orientation 
session. The orientation invitation can be seen in Appendix C. 
All eligible participants according to the initial telephone screen were invited to an in-
person 60-minute orientation session at the PAWMRC where the principal investigator described 
the complete details of the study. Participants were encouraged to ask questions about the study at 
this time. After the orientation session, interested participants were asked to provide written 
informed consent, fill out the physical activity readiness questionnaire (PAR-Q), and provide a 
complete medical history as recommended by the American College of Sports Medicine. Potential 
subjects who attended the orientation session were allowed time to decide whether or not they 
44 
 wished to participate. Potential subjects were instructed to contact the principal investigator if they 
decided to participate at a later time. Participants were also required to obtain a medical doctor’s 
clearance to participate in the behavioral weight loss intervention with physical activity. The cost 
of obtaining this clearance was the responsibility of the participant. Participants provided written 
informed consent, a completed PAR-Q, completed medical history, and physician’s clearance prior 
to the baseline assessment. 
Eligible participants who provided their consent and obtained medical clearance were 
scheduled to complete a baseline assessment. Assessment measures and procedures included 
height, weight, resting blood pressure, dietary intake, anthropometrics, body composition, 
submaximal graded exercise test, and physical activity. Participants were also asked to fill out 
questionnaires prior to the assessment. These questionnaires were collected at the baseline 
assessment visit. These questionnaires included demographics, Paffenbarger Exercise Habits, 
Eating Behavior Inventory, Three-Factor Eating, Block Food Frequency, Sedentary Behavior, 
Exercise Outcomes and Barriers, and Physical Activity Self-Efficacy. Eligible subjects were 
randomized to one of three groups (Figure 4) using a stratified, randomized block design. 
Participants were stratified by gender (e.g. male, female) and ethnicity (e.g. Non-Hispanic White, 
African-American, etc.). All of these procedures were approved by the University of Pittsburgh 
Institutional Review Board prior to the study beginning. 
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Figure 4. Study Progression 
3.3 EXPERIMENTAL DESIGN 
This study was a 12-week randomized trial designed to examine the effects of three 
different physical activity programs (SUP-PA, UNSUP-PA, and STEP) on physical activity 
participation, compensatory changes in physical activity, cardiorespiratory fitness, weight, and 
body composition during a SBWP. Secondary aims of this study included examining the effects 
of these programs on resting blood pressure, waist circumference measures, physical activity self-
efficacy, and energy intake. Compliance to the prescribed physical activity program was assessed 
throughout the 12-week program using self-report methods, with additional objective monitoring 
of physical activity outcomes assessed at baseline, 4-weeks, 8-weeks, and at 12-weeks. The other 
outcome measures were assessed at pre-intervention (0-weeks) and post-intervention (12-weeks). 
The intervention was conducted at the University of Pittsburgh PAWMRC. Upon completion of 
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 the baseline assessments, subjects were randomized to one of three intervention conditions using 
a stratified randomized block design: 1) SUP-PA, 2) UNSUP-PA, 3) STEP. Participants were 
stratified by gender (e.g. male and female) and ethnicity (e.g. Non-Hispanic White and African 
American). The study timeline is illustrated in Figure 5. 
 
 
Figure 5. Study Timeline 
3.4 STANDARD BEHAVIORAL WEIGHT LOSS PROGRAM 
The 12-week SBWP was conducted at the University of Pittsburgh Physical Activity and 
Weight Management Research Center. Participants attended weekly group meetings for all 12 
47 
 weeks of the study. SUP-PA, UNSUP-PA, and STEP each had separate group intervention 
sessions to avoid contamination of the physical activity prescriptions. Group meetings lasted 
approximately 30-45 minutes in duration and were led by trained behavioral interventionists with 
previous experience facilitating behavioral weight loss intervention meetings. These meetings 
focused on strategies to promote long-term behavior change and weight management including 
physical activity and caloric restriction. Non-exercise physical activity (e.g., slow walking, 
fidgeting, postural changes, etc.) are often recommended to increase energy expenditure and 
ultimately promote weight loss in most SBWP. However, because this study was evaluating how 
three different physical activity programs affect the total activity pattern of individuals, there were 
no comments made about non-exercise physical activity. (STEP was encouraged to increase total 
daily steps, but no other comments were made about non-exercise physical activity.) Strategies to 
promote behavior change included the Social Cognitive Theory, Problem Solving Theory, and 
Relapse Prevention. Self-efficacy was also a part of these lessons. Physical activity self-efficacy 
was an outcome measure of this study, thus, lessons focusing on self-efficacy were controlled 
across all groups. Participants were weighed weekly prior to group meetings to track changes in 
weight throughout the study and assist interventionists with weight counseling. Participants who 
did not attend the weekly group meeting were contacted via telephone call to reschedule for an 
individual weigh-in and make-up session with an interventionist prior to the next group meeting. 
If an individual make-up session was not scheduled, an interventionist would provide a brief 
counseling session by telephone and the written materials were mailed to the participant. The 
duration of group and individual sessions were recorded for fidelity purposes.  
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 3.4.1 Engagement and Retention 
Participants who did not attend the weekly group meeting were contacted via telephone 
call to reschedule for an individual weigh-in and make-up session with an interventionist prior to 
the next group meeting. If an individual make-up session could not be scheduled, an interventionist 
provided a brief counseling session by telephone and the written materials were mailed to the 
participant. If a participant missed a weekly meeting and study staff was unable to contact the 
participant via telephone, an email was sent to the participant. If the participant did not respond to 
the email, a formal letter was sent to the participant to determine their participation status. Study 
staff continued to attempt to contact the participant on a weekly basis until the participant was 
contacted or until the end of the 12-week intervention.  
3.4.2 Dietary Component 
Dietary recommendations were based on the participants’ baseline body weight.175  Caloric 
intake and fat intake goals are shown in Table 2. These calorie goals were based on intake 
recommendations that have been successful in other weight loss programs, and fat intake goals are 
consistent with the USDA Dietary Guidelines.97,175 
Table 2. Recommended Caloric and Fat Intake by Body Weight 
Initial Body Weight Kcal/Day Fat Grams/Day 
<200 lbs. 1200 26-40 
200 to <250 lbs. 1500 33-50 
≥250 lbs.  1800 40-60 
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  To promote adoption and adherence to these recommendations, participants were provided 
meal plans and sample recipes. Participants were provided paper diaries to self-monitor their eating 
behaviors, however, participants were allowed to use self-monitoring techniques such as 
MyFitnessPal, LoseIt, or other smartphone applications if they preferred. Participants were taught 
how to read nutrition labels and monitor food intake using The Calorie King Calorie, Fat, and 
Carbohydrate Counter.176 Participants were instructed to self-monitor daily and were instructed to 
turn in self-monitoring food diaries to their interventionist prior to group intervention meetings. 
Printed intervention lessons also included information related to behavior strategies for achieving 
the recommended calorie and fat intake goals. 
3.4.3 Physical Activity Component 
3.4.3.1 Supervised Physical Activity Program 
SUP-PA: Participants reported to a fitness facility (University of Pittsburgh Physical 
Activity and Weight Management Research Center) to engage in supervised physical activity 
sessions. Participants engaged in aerobic physical activity utilizing treadmills, elliptical trainers, 
adaptive motion trainers, and stationary cycles that were available at this facility. MVPA was 
prescribed at 100 min/wk for weeks 1-2, 125 min/wk for weeks 3-4, and 150 min/wk for weeks 5-
12. This dose of physical activity was spread across 3-5 supervised sessions per week (allowed 
flexibility for the participant), with each supervised session being at least 10 minutes. Physical 
activity was completed at 60-75% of age-predicted maximal heart rate, which was monitored using 
a Polar heart rate monitor. These physical activity sessions were closely monitored by exercise 
physiologists under the supervision of the Principal Investigator. The exercise physiologists 
recorded attendance, duration of physical activity session, monitored the heart rate of the physical 
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 activity sessions, and provided instruction on safe use of exercise equipment. Additionally, the 
exercise physiologist recorded three heart rates for each participant during each physical activity 
session. The average of those three heart rates was recorded as the heart rate for that particular 
physical activity session. SUP-PA was not instructed on physical activity behaviors outside of the 
supervised physical activity session. A behavioral interventionist monitored each participant’s 
supervised physical activity according to the log book kept by the exercise physiologist and 
provided appropriate feedback. The behavioral interventionist reinforced the importance of the 
supervised physical activity sessions.  
3.4.3.2 Unsupervised Physical Activity Program 
UNSUP-PA: Participants attended regular group sessions as part of the SBWP held at the 
University of Pittsburgh Physical Activity and Weight Management Research Center. During the 
first group session participants were anchored to the physical activity prescription, educated on 
appropriate monitoring of physical activity intensity, and educated on issues related to safety. 
Participants were anchored to MVPA using a validated Ratings of Perceived Exertion (RPE) 
Scale.177 Participants were asked to participate in activity that was of at least a moderate intensity 
(RPE 12-14). Similar to SUP-PA, MVPA were prescribed at 100 min/wk for weeks 1-2, 125 
min/wk for weeks 3-4, and 150 min/wk for weeks 5-12.  This dose of activity was to be spread 
across at least 3 days each week in activity sessions of >10 minutes. Participants were provided a 
self-monitoring paper diary to record their MVPA. A member of the study staff collected self-
monitored physical activity minutes weekly. These self-reported physical activity minutes were 
utilized by the behavioral interventionist for goal-setting and motivational purposes.  
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 3.4.3.3 Steps/day Physical Activity Program 
STEP: Participants attended regular group sessions as part of the SBWP held at the 
University of Pittsburgh Physical Activity and Weight Management Research Center. During the 
first group session participants were anchored to the physical activity prescription, educated on 
appropriate monitoring of physical activity intensity, and educated on issues related to safety. 
Participants were prescribed 6,000 steps/day for weeks 1-2, 8,000 steps/day for weeks 3-4, and 
10,000 steps/day for weeks 5-12.  To monitor steps, participants were provided a digital 
pedometer. Participants were instructed that 25% of these daily steps should be completed at a 
perceived “brisk” pace. Each participant was instructed to engage in 1,500 brisk steps/day during 
weeks 1-2, 2,000 brisk steps/day during weeks 3-4, and 2,500 brisk steps/day during weeks 5-12. 
This recommendation to increase the intensity of 25% of total steps per day was rationalized by 
an unpublished data analysis presented by Creasy et al. at the 2015 ACSM Annual Meeting.178 
Participants were anchored to “brisk walking” using a validated Ratings of Perceived Exertion 
(RPE) Scale similar to UNSUP-PA. Additionally, brisk walking is similar to walking at a pace of 
100 steps/minute.179 Thus, participants were also anchored to brisk walking by the message “Walk 
1,500 steps in 15 minutes.” Participants were provided a self-monitoring paper diary to record their 
daily steps. Similar to UNSUP-PA, study staff collected self-monitored daily steps on a weekly 
basis. These self-reported steps/day were utilized by the behavioral interventionist for goal-setting 
and motivational purposes. 
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 3.5 SELF-MONITORING 
3.5.1 Self-Monitoring Dietary Intake 
UNSUP-PA, SUP-PA, and STEP self-monitored dietary intake every day. Participants 
were given a self-monitoring paper diary to keep track of total calories and fat grams. The paper 
diaries also had the daily calorie and fat goals for each day in the program. This served as a 
reminder for the study participants. The diaries allowed participants to keep track of the calorie 
and fat grams of all food items consumed throughout the day, including meals and snacks. These 
data were strictly used for intervention purposes. Interventionists reviewed the paper diaries 
weekly and provided constructive, personalized feedback to the participants with the overall goal 
of helping the participant to lose weight. If for any reason a participant demonstrated eating 
behaviors that were inconsistent with study recommendations, they were referred to a dietician. 
Furthermore, if a participant did not record dietary behaviors for seven consecutive days, an 
interventionist spoke with the participant about the importance of self-monitoring. 
3.5.2 Self-Monitoring Physical Activity 
Both UNSUP-PA and STEP self-monitored physical activity every day. Participants were 
given a self-monitoring paper diary to keep track of physical activity (minutes or steps). The paper 
diaries also had the weekly goals associated with each week in the program. This served as a 
reminder for the study participants. Participants in UNSUP-PA recorded structured physical 
activity minutes in bouts of ≥10 minutes at an RPE of 12-14. These data were self-monitored and 
a device was not used to keep track of physical activity minutes. Participants in STEP recorded 
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 steps/day according to the digital pedometer they were given by study staff. Steps/day were 
recorded daily covering all waking activity in a 24-hour period. The participant was instructed to 
record steps/day each night prior to going to sleep. Once the participant recorded the steps/day, 
he/she was instructed to clear the pedometer prior to using the device the next day.   
3.6 SUMMARY 
Table 3 outlines the treatment components for all three groups. SUP-PA, UNSUP-PA, and 
STEP received a behavioral intervention focusing on strategies for weight loss. SUP-PA was not 
instructed on physical activity outside of the supervised physical activity session.  
Table 3. Intervention Treatment Components  
Frequency and Type of Contact SUP-PA UNSUP-PA STEP 
• Weekly Group Intervention Meetings (Weeks 1-12) X X X 
• In-person Supervised Exercise  
(No behavior change strategies were employed) 
 
X 
  
Physical Activity Prescription    
• Weekly Supervised Exercise Sessions  
(3-5 days/week for Weeks 1-12) 
X   
• Monitoring of physical activity frequency, type, 
duration, and intensity by exercise physiologist  
X   
• Pedometer   X 
• Physical activity paper diaries for self-monitoring  X X 
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 3.7 ASSESSMENT PROCEDURES 
Complete assessments were conducted at weeks 0 and 12 at the University of Pittsburgh 
Physical Activity and Weight Management Research Center. Each assessment took approximately 
60 to 90 minutes to complete. During the assessment visit, measurements of height, weight, BMI, 
body composition and anthropometry, resting heart rate and blood pressure, cardiorespiratory 
fitness, physical activity, dietary intake and eating behaviors, and a variety of survey instruments 
were assessed. At the 12-week assessment, treatment satisfaction was also assessed. Participants 
were compensated for the 12-week assessment visit. Additionally, physical activity was assessed 
at weeks 4 and 8. 
3.7.1 Height, Weight, Body Mass Index 
Height was measured to the nearest 0.1 centimeter (cm) at week 0 and week 12 using a 
wall-mounted stadiometer (Perspective Enterprises; Portage, MI). Two measurements were taken. 
If the two measurements were not within 0.5 cm of each other, a third measurement was taken and 
an average of all three measurements was used as for data analyses. If the third measurement was 
not needed, an average of the first two measurements was used for data analyses.  
Body weight was measured using a calibrated Tanita WB-110A digital scale (Tanita 
Corporation; Arlington Heights, IL) to the nearest 0.1 kilogram (kg) at week 0 and week 12. 
Participants were weighed two times in succession while wearing a lightweight hospital gown. If 
the two measurements were not within 0.2 kg, a third measurement was taken. The average of the 
measurements was used for data analyses. BMI was calculated as body weight in kilograms 
divided by height in meters squared (kg/m2). 
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 3.7.2 Body Composition and Anthropometry 
Body composition was assessed via dual-energy x-ray absorptiometry (DXA) using the GE 
Lunar iDXA (GE Healthcare; Little Chalfont, UK) at weeks 0 and 12. Full-body DXA scans 
provide data for fat mass, fat-free mass, percent body fat, and bone mineral density. Non-
pregnancy was confirmed in females prior to the DXA measure through a urine pregnancy test. 
The DXA scans were performed by trained staff who have been certified to perform these scans 
properly and safely.  
Waist and hip circumferences were assessed using a Gulick measuring tape measured to 
the nearest 0.1 cm. Two different waist circumference measures were taken. One waist 
circumference was measured in the horizontal plane directly at the umbilicus and the other waist 
circumference was taken at the level of the iliac crest. Hip circumference was taken at the largest 
circumference in the horizontal plane at the largest part of the hips above the gluteal fold. Two 
measurements were taken at each site. A third measurement was taken if the first two 
measurements differed by more than 1.0 cm. The average of the measurements was recorded for 
data collection. In addition, the average waist measurement was divided by the average hip 
measurement to derive the waist-to-hip-ratio. 
3.7.3 Resting Blood Pressure and Heart Rate 
Resting blood pressure was assessed using a Dinamap automated blood pressure cuff (GE 
Healthcare; Little Chalfont, UK) at weeks 0 and 12. The participants were seated at rest (i.e., sitting 
upright with feet flat on floor) for 5 minutes prior to the assessment of the blood pressure. Two 
blood pressures were taken with one minute in between each measurement. If systolic blood 
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 pressure differed by >10 mmHg or if diastolic blood pressure differed by >6 mmHg between the 
two measurements, a third measurement was taken. To determine the proper cuff size, study staff 
assessed arm circumference using a Gulick measuring tape. The arm circumference was taken at 
the midpoint between the acromion process and the olecranon process. Cuff size was determined 
using Table 4. 
Table 4. Blood Pressure Cuff Sizes 
 Cuff Size 
17.0 to < 4.0 cm Adult small 
24.0 to <33.0 cm Adult 
33.0 to <41.0 cm Large Adult 
≥41.0 cm Thigh or Large Adult Long 
 
The average of the blood pressure measurements was used for data analyses. If the mean 
systolic blood pressure at baseline was >150 mmHg or mean diastolic blood pressure was >100 
mmHg the participant was excluded from the study and referred to his/her physician.  Referral to 
the primary care physician also occurred if systolic blood pressure was >140 mmHg and <150 
mmHg or mean diastolic blood pressure was >90 mmHg and <100 mmHg; however, they were 
not excluded from participation provided that they were granted secondary clearance from their 
physician. 
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 3.7.4 Physical Activity 
Physical activity was assessed using the SenseWear device (BodyMedia Inc.; Pittsburgh, 
PA) at weeks 0, 4, 8, and 12. The SenseWear device is a multi-sensor device that collects minute-
by-minute physical activity data and has been previously validated.180 Participants wore the device 
during assessment periods all waking hours for seven consecutive days. Participants were 
instructed to take off the device while sleeping, showering, swimming, and bathing. Participants 
completed a Physical Activity Device Tracking Form during the seven-day period, which monitors 
days worn, time the device was worn, and if the device was removed for any reason. Additionally, 
the SenseWear device is able to notify the investigators the dates and times the device was worn. 
Criteria for valid physical activity data were similar to what has been used in other studies 
evaluating physical activity (≥4 days with ≥10 hours/day of wear time). Compensatory changes in 
physical activity were also be assessed using the SenseWear device. Data from the device were 
used to identify changes in steps, sedentary activity, light-intensity activity, and MVPA performed 
in 1, 5, 10, and 20 minute bouts.  
The Paffenbarger Exercise Habits Questionnaire181 was also used to gather data on specific 
types of activities that participants report, and the questionnaire used in the EARLY trials182 was 
used to collected data on self-reported sedentary behavior. 
3.7.5 Cardiorespiratory Fitness 
Cardiorespiratory fitness was measured using a submaximal graded exercise test at weeks 
0 and 12.  This graded exercise test started at 3.0 mph and 0% grade. The grade of the treadmill 
increased 1.0% each minute until the participant reached 85% of their age predicted maximal heart 
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 rate. The equation that was used to predict maximal heart rate was 220- age. This exercise test 
protocol has been shown to be sensitive to detecting change in fitness, without the participant 
burden or added cost of a maximal exercise test. Fitness was defined as the oxygen consumption, 
measured via a CareFusion Encore Metabolic Cart (CareFusion Corporation; San Diego, CA), at 
the point of test termination. Heart rate and blood pressure were assessed throughout the test. These 
tests were performed under the supervision of an ACSM certified clinical exercise physiologist to 
ensure participant safety. ACSM criteria for early test termination were followed to enhance 
participant safety. 
3.7.6 Dietary Intake 
Energy intake (kilocalories per day) and macronutrient composition, dietary intake were 
measured at week 0 and 12 using the Block Food Frequency Questionnaire (FFQ) (Dietary Data 
Systems; Berkeley, CA).183 Participants were instructed to complete this questionnaire prior to the 
assessment visit and brought the questionnaire on the day of the assessment.  
3.7.7 Additional Survey Instruments 
Additional survey instruments were completed at 0 and 12 weeks.  Physical activity 
barriers were assessed using the Exercise Outcomes and Barriers Questionnaire developed by 
Steinhardt and Dishman.27 Self-efficacy for physical activity was assessed using the questionnaire 
developed by Marcus et al.184 This questionnaire was also adapted to allow assessment of 
perceived self-efficacy for continuing physical activity after the study period.  Eating behaviors 
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 associated with weight loss were assessed using the Eating Behavior Inventory185 and the Three-
Factor Eating Questionnaire.186 
At week 12, participants in SUP-PA, UNSUP-PA, and STEP were asked to rate their 
satisfaction with the physical activity program. Participants were also asked questions regarding 
their effort, satisfaction, and overall progress for changing physical activity. Questions included 
the following: 
1. What is your overall satisfaction with the weight management program received? 
(response options were “very dissatisfied”, “somewhat dissatisfied”, “somewhat 
satisfied”, “very satisfied”) 
2. Would you recommend this weight management program to others? (response options 
were “Yes”, “No”) 
3. What is your overall satisfaction with the physical activity program received? (response 
options were “very dissatisfied”, “somewhat dissatisfied”, “somewhat satisfied”, “very 
satisfied”) 
4. Would you recommend the physical activity program to others? (response options were 
“Yes”, “No”) 
5. Given the effort you put into the weight management program in this study, how 
satisfied are you with the progress you have made over the past 12 weeks? Would you 
recommend this weight management program to others? (response options were “very 
dissatisfied”, “somewhat dissatisfied”, “somewhat satisfied”, “very satisfied” and 
“Yes”, “No”) 
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 3.8 SAFETY PROCEDURES 
Participant safety was also monitored throughout the 12-week intervention. Investigators 
evaluated mood, eating behaviors, medications, and medical events to ensure participant safety. 
The Centers of Epidemiological Studies Depression Scale (CES-D) was asked at week 0 and week 
12.187 This questionnaire was used to determine if the subject was experiencing depressive 
symptoms that needed medical follow-up. The Eating Disorder Diagnostic Scale (EDDS) was 
completed at week 0 and week 12.188  This questionnaire was used to determine if the subject was 
engaging in unhealthful eating behaviors during this study that required medical follow-up. 
Participant medications were also tracked at week 0 and week 12 to confirm eligibility and to have 
data on changes in medication that may influence study outcomes. Participants were also queried 
on medical events and serious adverse events at assessment visits. Serious adverse events were 
reported to the Institutional Review Board as per regulations. 
3.9 RENUMERATION FOR VISITS 
Participants were compensated $75 for completing the 12-week assessment. Participants 
were also compensated $10 for wearing the SenseWear device at week 4 and week 8 for a total of 
$20 if the device was worn for both time points. Thus, participants were compensated a total of 
$95 if they completed all assessment procedures. 
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 3.10 STATISTICAL ANALYSES 
Statistical analyses were performed using SPSS software (IBM-SPSS, version 24). 
Statistical significance was accepted at p≤0.05. Analyses were performed to examine if data were 
normally distributed. Normally distributed data are presented as mean ± standard deviation (SD). 
When data were not normally distributed, non-parametric tests were performed or proper 
transformations were conducted. Data that were not normally distributed are presented as median 
(25th, 75th percentiles). Intervention data were analyzed using a one-way ANOVA to compare data 
across the UNSUP-PA, SUP-PA, and STEP interventions. Chi-square was used for categorical 
data.  
Descriptive statistics were used to describe the study sample at baseline, with one-way 
analysis of variance (ANOVA) used to compare baseline data across randomized groups (SUP-
PA, UNSUP-PA, STEPS). Mean baseline values that were assessed include: age, weight, BMI, 
physical activity, fitness, blood pressure, dietary intake, waist circumference, and body 
composition. Data that were not normally distributed were analyzed using a Kruskal-Wallis Test. 
For significant effects, pairwise comparisons (SUP-PA vs. UNSUP-PA, SUP-PA vs. STEPS, 
UNSUP-PA vs. STEPS) were examined using a Bonferroni adjusted p-value for multiple 
comparisons.  
Changes in MVPA, the primary outcome, other forms of physical activity, and sedentary 
behavior measured from the SenseWear device at 0, 4, 8, and 12 weeks. Primary outcomes were 
analyzed using a repeated measures ANOVA. Significance for the effects of treatment group, time, 
and group by time interaction were examined. Differences between SUP-PA, UNSUP-PA, and 
STEP groups were examined over time with the p-value adjusted for multiple comparisons using 
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 the Bonferroni procedure. Additional outcomes were assessed using a similar method with 2 time 
points (0 and 12 weeks). 
3.11 POWER ANALYSIS 
The primary aim of this study was to provide feasibility data to justify an appropriately 
powered long-term study. Given the pilot nature of this study, there were minimal data available 
to inform an effect size for between group comparisons. Based on a previous study conducted by 
Perri et al., the anticipated standard deviation for MVPA was 26.05 minutes.22 It was hypothesized 
that a statistically meaningful difference in MVPA would be 20 minutes/week. With 80% power 
and a type one error rate of .05, adjusted to .025 for the multiple comparisons of STEP vs. SUP-
PA and UNSUP-PA vs. SUP-PA, it was estimated that 17 participants per group would be needed. 
Therefore, a total of 51 participants were needed. Based on past studies at the Physical Activity 
and Weight Management Research Center we anticipated 90-95% retention across the study 
period. In order to allow for attrition, we proposed to enroll 60 subjects; this would allow for an 
attrition rate of 3 participants per group which was higher than the hypothesized attrition rate. 
Power calculations were conducted using G*Power, version 3.1.9.2.
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 4.0  RESULTS 
The primary aim of this study was to compare the effectiveness of a supervised physical 
activity program prescribed in minutes per week (SUP-PA), unsupervised physical activity 
program prescribed in minutes per week (UNSUP-PA), and an unsupervised program prescribed 
in steps per day (STEP) during a behavioral weight loss intervention in adults who were 
overweight or obese. This was a 12-week randomized weight loss trial with assessments at baseline 
(0 weeks) and post-intervention (12 weeks). All study related procedures (physical assessments, 
behavioral intervention, and exercise sessions) were conducted at the University of Pittsburgh 
Physical Activity and Weight Management Research Center (PAWMRC). The results are 
presented below. 
4.1 STUDY PARTICIPANTS 
Fifty-two (N=52) inactive adults between the ages of 18-55 years old with a BMI of 25.0 
to <40.0 were randomized in this trial. Mean age was 43.5 ± 10.1 years and mean BMI was 31.5 
± 3.5 kg/m2, with 26.9% males and 32.7% non-white participants. Baseline characteristics are 
shown in Table 5. There was a significant difference in baseline cardiorespiratory fitness (peak 
oxygen consumption during the submaximal treadmill test) between groups (p=0.038). Post hoc 
analysis with Bonferroni adjustment revealed that STEP and UNSUP-PA were statistically 
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 different (p<.05).  One-way analysis of variance (ANOVA) and Pearson Chi-Square revealed there 
were no other significant differences between the groups.   
 
Table 5. Baseline Characteristics 
CHARACTERISTICS TOTAL 
N= 52 
Mean ± SD 
STEP 
N= 18 
Mean ± SD 
UNSUP-PA 
N= 17 
Mean ± SD 
SUP-PA 
N= 17 
Mean ± SD 
Age (years) 43.5 ± 10.1 39.3 ± 10.7 46.2 ± 10.1 45.2 ± 8.5 
Height (cm) 165.5 ± 9.0 168.2 ± 8.9 165.9 ± 6.8 162.3 ± 10.4 
Weight (kg) 86.4 ± 13.5 88.2 ± 14.5 86.5 ± 12.8 84.5 ± 13.6 
BMI (kg/m2) 31.5 ± 3.5 31.1 ± 3.8 31.3 ± 3.3 32.0 ± 3.5 
Sex     
        Male N,% 14, 26.9% 5, 27.8% 5, 29.4% 4, 23.5% 
        Female N,% 38, 73.1% 13, 72.2% 12, 70.6% 13, 76.5% 
Race     
        White N, % 35, 67.3% 12, 66.7% 11, 64.7% 12, 70.6% 
        Non-white N,% 17, 32.7% 6, 33.3% 6, 35.3% 5, 29.4% 
        Black or African American N, % 12, 23.1% 3, 16.7% 5, 29.4% 4, 23.5% 
        Asian N, % 5, 9.6% 3, 16.7% 1, 5.9% 1, 5.9% 
Peak VO2 (ml/kg/min) 25.2 ± 5.0 27.7 ± 5.4 23.7 ± 4.2 24.1 ± 4.4 
 
4.2 STUDY RECRUITMENT AND RETENTION 
Figure 6 illustrates recruitment, randomization, and retention. A total of 247 telephone calls 
were received by study staff from potential participants expressing interest in the study, and 174 
(70.4%) consented for the telephone screening. Of the individuals screened, 83 (47.7%) were 
eligible for the study and invited to an orientation session at the PAWMRC. Sixty-nine individuals 
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 attended the orientation session with 63 consenting to participate in the study (Appendix D). Fifty-
two individuals completed the baseline assessment and were randomized to STEP, SUP-PA, or 
UNSUP-PA. Reasons for ineligibility and reasons for not being randomized are provided in Figure 
6. 
 
 
Figure 6. Consort Diagram 
 
Forty-nine participants (94.2%) completed the baseline and 12-week physical assessment. 
Participants who did not complete the 12-week assessment will be referred to as “non-completers” 
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 while participants completing both assessments will be referred to as “completers.” Baseline 
characteristics of completers and non-completers are shown in Table 6. All three non-completers 
were female and non-white. There was one non-completer in each treatment group (SUP-PA; 
N=1), (UNSUP-PA; N=1), (STEP; N=1). Because attrition was low and spread evenly across the 
treatment groups, only data from the completers’ analyses are presented. 
Table 6. Baseline Characteristics of Completers and Non-Completers 
CHARACTERISTICS Total Sample 
N=52 
Mean ± SD 
Completers 
N= 49 
Mean ± SD 
Age (years) 43.5 ± 10.1 43.2 ± 10.3 
Height (cm) 165.5 ± 9.0 165.5 ± 9.3 
Weight (kg) 86.4 ± 13.5 86.2 ± 13.7 
BMI (kg/m2) 31.5 ± 3.5 31.4 ± 3.5 
Sex   
        Male N,% 14, 26.9% 14, 28.6% 
        Female N,% 38, 73.1% 35, 71.4% 
Race   
        White N, % 35, 67.3% 35, 71.4% 
        Non-white N,% 17, 32.7% 14, 28.6% 
        Black or African American N, % 12, 23.1% 10, 20.4% 
        Asian N, % 5, 9.6% 4, 8.1% 
Dietary Intake (kcal/day) 1797 ± 838 1819 ± 823 
Self-Report Physical Activity (kcal/week) 863.7 ± 779.1 851.4 ± 735.9 
Systolic Blood Pressure (mmHg) 118.2 ± 10.7 118.3 ± 10.9 
Diastolic Blood Pressure (mmHg) 71.3 ± 8.7 71.4 ± 8.9 
Resting Heart Rate (bpm) 68.6 ± 10.9 68.7 ± 10.9 
VO2 Peak (ml/kg/min) 25.2 ± 5.0 25.5 ± 4.9 
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 4.3 CHANGE IN PHYSICAL ACTIVITY 
4.3.1 Objectively Measured Physical Activity 
Physical activity data were considered valid if the physical activity device was worn ≥ 4 
days and ≥ 10 hours/day. Analyses were also conducted using all participants with ≥ 1 day and ≥ 
10 hours/day. The pattern of the results were comparable, and therefore, the data for ≥ 1 day and 
≥ 10 hours/day are presented below. The data for wear time of ≥ 4 days and ≥ 10 hours/day are 
presented in Appendix A (Table 18). 
 At baseline, there were no significant differences between groups for any measures of 
physical activity. Treatment groups reported similar amounts of wear time (days/week and 
hours/day) across the 12-week intervention. Objectively measured physical activity data are 
presented in Table 7 and Table 8. 
A one-way ANOVA on the change in moderate-to-vigorous physical activity (MVPA, 
[≥3.0 METs in bouts of ≥10 minutes]) found no differences between the groups (p=0.70). All three 
groups significantly increased objectively measured MVPA completed in bouts of ≥10 minutes 
over the 12-week intervention (STEP: 11.5 ± 31.2 min/day, UNSUP-PA: 16.1 ± 25.8 min/day, and 
SUP-PA: 21.6 ± 24.9 min/day, p<0.001) with no differences between groups (p=0.94) or group by 
time interaction (p=0.81). Figure 7 illustrates the changes in MVPA minutes/week (≥3.0 METs in 
bouts of ≥10 minutes) during the 12-week intervention.  
There was a significant increase in the number of bouts/day of MVPA (≥3.0 METs in bouts 
of ≥10 minutes) for all three treatment groups over the course of the intervention (p<0.001) with 
no group effect (p=0.69) or group X time interaction (p=0.95). Intensity of the physical activity 
bouts also increased over time (p=0.01) with no group effect (p=0.43) or group by time interaction 
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 (p=0.68). Following the 12-week intervention, all three groups were engaging in a significant 
amount of MVPA (STEP: 47.0 ± 28.2 min/day, UNSUP-PA: 41.7 ± 44.5 min/day, SUP-PA: 49.6 
± 38.7 min/day) A similar pattern was observed when analyzing MVPA in bouts of >1 minute. 
Data are presented in Table 7 and Table 8. 
In addition, all treatment groups increased total steps/day (p<0.001) with no group 
differences (p=0.40) or interaction effect (p=0.79) (STEP: 2595 ± 2535, UNSUP-PA: 2133 ± 2909, 
SUP-PA: 1964 ± 1879). Following the 12-week intervention, STEP was taking 10323 ± 2538 
steps/day, UNSUP-PA was taking 9108 ± 3589 steps/day, and SUP-PA was taking 9229 ± 2187 
steps/day. MVPA steps/day completed in bouts of ≥10 minutes also increased in all three treatment 
groups (p<0.001) with no group differences (p=0.79) or interaction effect (p=0.94) (STEP: 1584 
± 2030, UNSUP-PA: 1420 ± 2418, SUP-PA: 1710 ± 1594). 
STEP, UNSUP-PA, and SUP-PA significantly decreased objectively measured sedentary 
time (SED) over the 12-week intervention (STEP: -61.0 ± 91.9 min/day, UNSUP-PA: -56.2 ± 94.0 
min/day, and SUP-PA: -62.8 ± 71.0 min/day, p<0.001) with no differences between groups 
(p=0.20) or group by time interaction (p=0.99). Because wear time may confound these results, 
analyses were also conducted with sedentary represented as a percentage of wear time. These 
analyses revealed the same pattern with all three groups significantly reducing SED over the 12-
week intervention (STEP: -8.6 ± 10.7%, UNSUP-PA: -6.4 ± 8.2%, SUP-PA: -6.9 ± 7.0%).  
All three treatment groups significantly increased Light-intensity physical activity (LPA) 
over the 12-week intervention (STEP: 69.7 ± 54.6 min/day, UNSUP-PA: 57.1 ± 88.7 min/day, and 
SUP-PA: 28.3 ± 49.5 min/day, p<0.001) with no differences between groups (p=0.27) or group by 
time interaction (p=0.30). 
69 
 Table 7. Changes in Objectively Measured Physical Activity 
Outcome Groups Assessment Periods P-Values 
  Baseline 4 Weeks 8 Weeks 12 Weeks Group Time Time X 
Group 
Days of Wear Time STEP (N=17) 6.8 ± 0.6 6.9 ± 0.3 6.5 ± 1.1 6.8 ± 0.4  
0.40 
 
0.02 
 
0.23 UNSUP-PA (N=16) 6.7 ± 0.9 6.8 ± 0.4 6.4 ± 0.8 6.8 ± 0.4 
SUP-PA (N=16)  6.7 ± 0.6 6.9 ± 0.4 6.5 ± 1.1 5.8 ± 1.9 
Hours of Wear 
Time/Day 
STEP (N=17) 14.3 ± 1.7 14.5 ± 1.4 14.4 ± 1.6 14.6 ± 1.6  
0.68 
 
0.41 
 
0.79 UNSUP-PA (N=16) 14.8 ± 1.0 14.9 ± 0.9 14.6 ± 1.2 14.8 ± 1.2 
SUP-PA (N=16)  14.5 ± 1.4 14.7 ± 1.4 14.4 ± 1.1 14.3 ± 1.1 
SED (min/day) STEP (N=17) 585.6 ± 113.6 579.2 ± 105.4 521.8 ± 126.3 524.7 ± 110.0  
0.20 
 
<0.001 
 
0.99 UNSUP-PA (N=16) 638.3 ± 106.4 621.3 ± 88.2 586.5 ± 103.0 582.1 ± 112.7 
SUP-PA (N=16)  583.7 ± 109.1 571.8 ± 114.8 517.9 ± 110.6 520.9 ± 129.1 
LPA (min/day) 
 
STEP (N=17) 189.3 ± 57.9 210.2 ± 62.2 252.7 ± 82.0 259.0 ± 65.3  
0.27 
 
<0.001 
 
0.30 UNSUP-PA (N=16) 174.0 ± 67.7 180.2 ± 66.7 199.8 ± 62.8 231.1 ± 81.2 
SUP-PA (N=16)  209.1 ± 82.8 216.7 ± 73.9 249.4 ± 90.5 237.4 ± 76.6 
MVPA (min/day) 
 
STEP (N=17) 60.9 ± 45.2 71.5 ± 33.3 76.9 ± 41.0 75.3 ± 40.2  
0.74 
 
<0.001 
 
0.98 UNSUP-PA (N=16) 49.2 ± 44.3 63.3 ± 49.8 67.6 ± 53.4 64.8 ± 50.2 
SUP-PA (N=16)  55.3 ± 46.9 75.4 ± 43.4 80.3 ± 53.8 75.3 ± 55.4 
Bouted MVPA 
(min/day) 
 
STEP (N=17) 35.4 ± 33.5 42.8 ± 23.6 51.2 ± 33.5 47.0 ± 28.2  
0.94 
 
<0.001 
 
0.81 UNSUP-PA (N=16) 25.6 ± 36.0 38.3 ± 42.6 46.1 ± 45.5 41.7 ± 44.5 
SUP-PA (N=16)  28.0 ± 23.5 44.4 ± 24.0 54.3 ± 37.2 49.6 ± 38.7 
Bouts of MVPA/Day  STEP (N=17) 1.6 ± 1.4 2.0 ± 1.1 2.1 ± 1.2 2.2 ± 1.3  
0.69 
 
<0.001 
 
0.95 UNSUP-PA (N=16) 1.2 ± 1.3 1.5 ± 1.2 1.8 ± 1.4 1.9 ± 1.6 
SUP-PA (N=16)  1.3 ± 1.2 1.8 ± 1.1 2.0 ± 1.6 2.0 ± 2.0 
Intensity of MVPA  
 
STEP (N=16) 4.4 ± 0.8 4.8 ± 0.9 4.9 ± 0.9 5.0 ± 1.1  
0.43 
 
0.01 
 
0.68 UNSUP-PA (N=11)  4.2 ± 0.6 4.7 ± 0.6 4.5 ± 0.8 4.5 ± 0.6 
SUP-PA (N=13 4.3 ± 0.4 4.5 ± 0.6 4.6 ± 0.7 4.7 ± 0.8 
SED: Sedentary Time (<1.5 METs) 
LPA: Light-Intensity Physical Activity (≥1.5 METs to <3.0 METs)  
MVPA: Moderate-to-Vigorous Physical Activity (≥3.0 METs in bouts of ≥1 minute) 
Bouted MVPA: (≥3.0 METs in bouts of ≥10 minutes)  
Intensity of MVPA: (average METs/ physical activity bout ≥10 minutes) 
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 Table 8. Physical Activity Comparisons across the 12-Week Intervention 
Outcome Groups Assessment Periods 
  Baseline 4 Weeks 8 Weeks 12 Weeks 
MVPA  
(Minutes/week ≥3.0 METs 
in bouts of ≥10 minutes) 
STEP (N=17) 
Change from Baseline 
248.1 ± 234.5 
 
299.4 ± 165.1 
51.3 ± 222.8 
358.4 ± 234.6 
110.3 ± 125.9 
328.7 ± 197.7 
80.6 ± 218.5 
UNSUP-PA (N=16) 
Change from Baseline 
179.3 ± 252.2 268.0 ± 298.5 
88.7 ± 166.6 
323.0 ± 318.8 
143.7 ± 220.8 
292.1 ± 311.3 
112.9 ± 180.4 
SUP-PA (N=16) 
Change from Baseline 
196.2 ± 164.8 
 
310.7 ± 168.2 
114.5 ± 106.7 
379.9 ± 260.4 
183.7 ± 178.2 
347.3 ± 270.7 
151.1 ± 174.0 
Total Steps 
(Steps/day) 
STEP  
Change from Baseline 
7728 ± 1456 
 
9883 ± 2142 
2155 ± 2329 
10267 ± 2251 
2539 ± 2095 
10323 ± 2538 
2595 ± 2535 
UNSUP-PA 
Change from Baseline 
6975 ± 2716 
 
8931 ± 4063 
1956 ± 3219 
8701 ± 3622 
1725 ± 2587 
9108 ± 3589 
2133 ± 2909 
SUP-PA 
Change from Baseline 
7265 ± 1875 
 
9458 ± 2388 
2193 ± 1703 
9980 ± 3114 
2715 ± 3189 
9229 ± 2187 
1964 ± 1879 
Bouted MVPA Steps 
(Steps/day at ≥3.0 METs in 
bouts of ≥10 minutes) 
STEP 
Change from Baseline 
2178 ± 1391 3579 ± 1615 
1401 ± 1632 
4067 ± 2149 
1888 ± 1677 
3762 ± 1762 
1584 ± 2030 
UNSUP-PA 
Change from Baseline 
1943 ± 2724 3415 ± 4066 
1472 ± 2698 
3480 ± 3738 
1537 ± 2284 
3363 ± 3534 
1420 ± 2418 
SUP-PA 
Change from Baseline 
1385 ± 826 
 
3148 ± 1601 
1763 ± 1419 
3859 ± 2506 
2475 ± 2729 
3096 ± 1451 
1710 ± 1594 
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Figure 7. Change in Objective MVPA completed in bouts of ≥ 10 minutes 
4.3.2 Subjective Measures of Physical Activity 
Self-reported physical activity (kcal/week) was not normally distributed so data were log 
transformed. Results from the repeated measures ANOVA showed a significant time effect 
(p<0.001), with no group effect (p=0.59) or group by time interaction (p=0.79).  Energy 
expenditure increased in STEP (949.5 ± 726.2 kcals/week at baseline, 1504.5 ± 576.1 kcal/week 
at week 12) UNSUP-PA (689.2 ± 620.6 kcals/week at baseline, 1468.4 ± 989.7 kcal/week at week 
12) and SUP-PA (840.1 ± 845.3 kcals/week at baseline, 1821.6 ± 816.2 kcal/week at week 12). 
There was no group effect (p=0.54) or group X time interaction (p=0.41). Analyses were also 
performed removing the stairs from the physical activity energy expenditure with the pattern of 
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 results similar to those presented above. Self-reported physical activity data are reported in Table 
9.  
At baseline, all three groups were engaging in similar amounts of self-report sedentary 
behavior on weekdays (STEP, 10.8 ± 3.5 hr/day), (UNSUP-PA, 14.3 ± 5.9 hr/day), (SUP-PA, 12.0 
± 4.1 hr/day). There was no significant group X time interaction effect; however, STEP increased 
weekday sedentary time (1.9 ± 5.3 hr/day) while SUP-PA (-1.1 ± 2.8 hr/day) and UNSUP-PA (-
0.1 ± 2.2 hr/day) decreased weekday sedentary time (p=0.08). There were no statistical differences 
between groups in self-reported sedentary time on weekend days (p=0.55), and there was no 
change in sedentary time on weekend days over the 12-week intervention (p=0.16). These data are 
reported in Table 9. 
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Table 9. Changes in Self-Reported Physical Activity and Sedentary Time 
  P-Values 
Outcome Group Baseline 12 Weeks Change Group Time Group 
X Time 
Sedentary Time 
Weekday (hr/day) 
STEP (N=17) 10.8 ± 3.5 12.7 ± 6.0 1.9 ± 5.3  
0.20 
 
0.67 
 
0.08 UNSUP-PA (N=16) 14.3 ± 5.9 14.2 ± 6.4 -0.1 ± 2.2 
SUP-PA (N=16)  12.0 ± 4.1 11.0 ± 3.5 -1.1 ± 2.8 
Sedentary Time 
Weekend (hr/day) 
STEP  9.0 ± 3.8 8.5 ± 4.7 -0.5 ± 4.1  
0.55 
 
0.16 
 
0.58 UNSUP-PA  10.5 ± 4.7 10.1 ± 6.9 -0.4 ± 4.4 
SUP-PA  10.2 ± 4.9 8.3 ± 3.4 -1.9 ± 4.7 
**Leisure-time 
Physical Activity 
with Stairs 
(kcal/wk) 
STEP  740 (460, 1712) 1388 (1118, 1785) 591 (213, 896)  
 
0.59 
 
 
<0.001 
 
 
0.79 
UNSUP-PA  420 (280, 712) 1259 (716, 2224) 578 (84, 1507) 
SUP-PA  560 (324, 1094) 1541 (1181, 2140) 889 (226, 1893) 
**Leisure-time 
Physical Activity 
without Stairs 
(kcal/wk) 
STEP  456 (192, 1439) 1170 (992, 1364) 619 (213, 818)  
 
0.56 
 
 
<0.001 
 
 
0.66 
UNSUP-PA  336 (24, 444) 1064 (450, 1736) 648 (126, 1453) 
SUP-PA  216 (72, 842) 1413 (1125, 1842) 1001 (298, 1701) 
**Data presented as median (25th, 75th Percentiles) 
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 4.4 CHANGE IN WEIGHT 
There was a significant time effect for BMI across STEP, UNSUP-PA, and SUP-PA 
(p<0.001), but there was no significant group X time interaction (p=0.55). STEP, UNSUP-PA, and 
SUP-PA reduced BMI by 1.9 ± 1.3 kg/m2, 1.8 ± 1.1 kg/m2, and 1.5 ± 1.2 kg/m2, respectively. 
Similarly, weight loss across the 12-week intervention was similar in all three groups STEP (-5.3 
± 3.6 kg), UNSUP-PA (-5.1 ± 3.3 kg), and (-3.8 ± 3.0 kg). There was a significant time effect 
(p<0.001), but there was no significant group X time interaction (p=0.36). Total weight loss for all 
the groups was 4.7 ± 3.3 kg. Percent weight loss for all the groups was 5.4 ± 3.7%. There were no 
significant differences in percent weight loss between STEP, UNSUP-PA, and SUP-PA.  Results 
are shown in Table 10.  
Weight loss of 5% has been suggested as the minimal goal of behavioral weight loss 
interventions;189 thus, STEP, UNSUP-PA, and SUP-PA were further examined based upon 
achievement of 5% weight loss. These data are presented in Table 11. Adjusted for multiple 
comparisons, Chi Square analyses demonstrated that STEP and UNSUP-PA had more individuals 
attain 5% weight loss compared to SUP-PA (p<0.05). Individual weight loss patterns by group are 
illustrated in Figure 8.  
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 Table 10. Change in Weight, Body Composition, and Anthropometrics 
  P-Values 
Outcome Group Baseline 12 Weeks Change Group Time Group X 
Time 
BMI (kg/m2) STEP (N=17) 30.9 ± 3.8 29.0 ± 3.5 -1.9 ± 1.3  
0.59 
 
<0.001 
 
0.55 UNSUP-PA (N=16) 31.3 ± 3.4 29.5 ± 3.3 -1.8 ± 1.1 
SUP-PA (N=16)  32.0 ± 3.6 30.5 ± 3.4 -1.5 ± 1.2 
Weight (kg) STEP (N=17) 87.7 ± 14.7 82.3 ± 14.1 -5.3 ± 3.6  
0.81 
 
<0.001 
 
0.36 UNSUP-PA (N=16) 86.8 ± 13.1 81.6 ± 11.8 -5.1 ± 3.3 
SUP-PA (N=16)  84.0 ± 13.7 80.1 ± 13.2 -3.8 ± 3.0 
Percent Weight 
Change (%) 
STEP (N=17)   -6.0 ± 4.0    
UNSUP-PA (N=16)   -5.8 ± 3.6 0.43   
SUP-PA (N=16)    -4.5 ± 3.5    
Fat mass (kg) STEP (N=17) 33.7 ± 6.3 29.6 ± 6.2 -4.1 ± 2.4  
0.77 
 
<0.001 
 
0.95 UNSUP-PA (N=16) 35.4 ± 7.6 31.3 ± 8.2 -4.0 ± 2.8 
SUP-PA (N=15)  34.6 ± 6.7 30.8 ± 6.4 -3.8 ± 2.8 
Fat Free Mass (kg) STEP (N=17) 50.9 ± 10.5 49.7 ± 10.5 -1.2 ± 1.7  
0.69 
 
<0.001 
 
0.06 UNSUP-PA (N=16) 48.2 ± 9.9 47.2 ± 9.3 -1.0 ± 1.1 
SUP-PA (N=15)  47.3 ± 11.1 47.3 ± 11.2 -0.1 ± 1.4 
Total Body Fat (%) STEP (N=17) 38.7 ± 4.6 36.2 ± 5.6 -2.5 ± 2.1  
0.49 
 
<0.001 
 
0.96 UNSUP-PA (N=16) 41.1 ± 6.9 38.5 ± 8.4 -2.6 ± 2.3 
SUP-PA (N=15)  41.2 ± 6.8 38.5 ± 7.2 -2.7 ± 2.2 
Tissue Body Fat (%) STEP (N=17) 39.9 ± 4.7 37.5 ± 5.7 -2.5 ± 2.1  
0.50 
 
<0.001 
 
0.96 UNSUP-PA (N=16) 42.4 ± 7.0 39.8 ± 8.5 -2.6 ± 2.4 
SUP-PA (N=15)  42.5 ± 6.9 39.7 ± 7.3 -2.7 ± 2.2 
Waist Circumference 
(umbilicus, cm) 
STEP (N=17) 99.8 ± 11.1 94.1 ± 9.9 -5.7 ± 5.3  
0.55 
 
<0.001 
 
0.89 UNSUP-PA (N=16) 102.9 ± 9.1 97.1 ± 8.5 -5.8 ± 4.5 
SUP-PA (N=15)  103.4 ±  9.9 96.9 ± 9.1 -6.5 ± 4.6 
Waist Circumference 
(iliac, cm) 
STEP (N=17) 100.1 ± 9.6 94.6 ± 8.4 -5.5 ± 5.8  
0.68 
 
<0.001 
 
0.32 UNSUP-PA (N=16) 101.8 ± 6.8 97.9 ± 8.3 -3.9 ± 5.6 
SUP-PA (N=15)  101.8 ± 9.2 94.7 ± 9.3 -7.0 ± 5.9 
Hip Circumference 
(cm) 
STEP (N=17) 109.5 ± 8.8 105.3 ± 7.1 -4.2 ± 3.9  
0.67 
 
<0.001 
 
0.65 UNSUP-PA (N=16) 109.8 ± 6.5 105.7 ± 7.3 -4.0 ± 2.7 
SUP-PA (N=15)  111.3 ± 9.2 108.1 ± 8.1 -3.2 ± 3.2 
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 Table 11. Achievement of 5% Weight Loss by Group at Week 12 
Group Did not Achieve 5% 
Weight Loss 
Achieved 5%  
Weight Loss 
Percent of Group 
Achieving 5% Weight Loss 
STEP (N=17) 5 12 67%   A 
UNSUP-PA (N=16) 5 11 65%   B 
SUP-PA (N=16)  11 5 31%  A,B 
TOTAL (N=49) 21 28                 57% 
Groups with the same letters are significantly different at p<0.05 
 
 
 
Figure 8. Individual Percent Weight Loss by Group at Week 12 (N=49) 
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 4.5 CHANGE IN BODY COMPOSITION 
There were significant reductions in waist circumference measured at the umbilicus 
(p<0.001) and the iliac crest (p<0.001) at 12 weeks for STEP (umbilicus: -5.7 ± 5.3 cm, iliac crest: 
-5.5 ± 5.8 cm), UNSUP-PA (umbilicus: -5.8 ± 4.5 cm, iliac crest: -3.9 ± 5.6 cm), and SUP-PA 
(umbilicus: -6.5 ± 4.6 cm, iliac crest: -7.0 ± 5.9 cm). There were no differences observed between 
groups for waist circumference at the umbilicus (p=0.55) or iliac crest (p=0.68) measurements and 
there were no significant group X time interactions (umbilicus: p=0.89, iliac crest: p=0.32). 
Similarly, there was a significant time effect for hip circumference (p<0.001) in STEP (-4.2 ± 3.9 
cm), UNSUP-PA (-4.0 ± 2.7 cm), and SUP-PA (-3.2 ± 3.2 cm), but there was no significant group 
effect (p=0.65) or group by time interaction (p=0.67).  
There were significant reductions in fat mass (p<0.001) at 12 weeks for STEP (-4.1 ± 2.4 
kg), UNSUP-PA (-4.0 ± 2.8 kg), and SUP-PA (-3.8 ± 2.8 kg). There was no significant difference 
observed between groups for fat mass (p=0.77) and there was no significant group X time 
interaction (p=0.95). There were significant reductions in total percent body fat (p<0.001) and 
tissue percent body fat (p<0.001) at 12 weeks for STEP (total: -2.5 ± 2.1 kg, tissue: -2.5 ± 2.1 kg), 
UNSUP-PA (total: -2.6 ± 2.3 kg, tissue: -2.6 ± 2.4 kg), and SUP-PA (total: -2.7 ± 2.2 kg, tissue: -
2.7 ± 2.2 kg). There were no significant differences observed between groups for total percent fat 
(p=0.49) or tissue percent fat (p=0.50) and there were no group X time interactions (total: p=0.96, 
tissue: p=0.96). In addition, there were was a significant time effect for lean mass (p<0.001) in 
STEP (-1.2 ± 1.7 kg), UNSUP-PA (-1.0 ± 1.1 kg), and SUP-PA (-0.1 ± 1.4 kg), but there was no 
significant group effect (p=0.69) or group by time interaction (p=0.06). Results are shown in Table 
10.  
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 4.6 CHANGE IN CARDIORESPIRATORY FITNESS 
Cardiorespiratory fitness improved over the 12-week intervention (p<0.001). There was a 
significant group X time interaction effect for cardiorespiratory fitness (p=0.01). Bonferroni 
adjusted post hoc analysis revealed that SUP-PA (3.8 ± 1.6 ml/kg/min) and UNSUP-PA (3.8 ± 3.2 
ml/kg/min) had a greater improvement in fitness compared to STEP (1.3 ± 2.4 ml/kg/min) 
(p<0.05). There was no statistical difference between SUP-PA and UNSUP-PA for change in 
cardiorespiratory fitness.  
Because weight change could be a potential confounder when interpreting changes in 
relative VO2 (ml/kg/min), analyses were also performed using absolute VO2 (L/min) and treadmill 
time (minutes until test termination). When examining treadmill time, there were was a significant 
improvement across the intervention in all three groups (p<0.001). However, there was no 
significant group X time interaction (p=0.41). Measures of peak absolute VO2 improved 
significantly over the 12-week intervention. There was a significant group X time interaction with 
UNSUP-PA (0.17 ± 0.24 L/min) and SUP-PA (0.22 ± 0.23 L/min) improving more than STEP (-
0.04 ± 0.19 L/min) (p<0.01). Cardiorespiratory fitness data are presented in Table 12.  
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 Table 12. Change in Cardiorespiratory Fitness, Resting Blood Pressure, and Heart Rate 
  P-Values 
Outcome Group Baseline 12 Weeks Change Group Time Group 
X 
Time 
Resting Heart 
Rate (bpm) 
STEP (N=17) 64.5 ± 10.2 61.0 ± 8.3 -3.5 ± 10.3  
0.24 
 
<0.001 
 
0.07 UNSUP-PA (N=16) 70.7 ± 11.2 64.5 ± 9.2 -6.2 ± 9.7 
SUP-PA (N=16)  71.0 ± 10.7 59.8 ± 6.2 -11.3 ± 8.7 
Resting Systolic 
Blood Pressure 
(mmHg) 
STEP  115.8 ± 10.5 113.0 ± 11.6 -2.8 ± 7.6  
0.51 
 
<0.01 
 
0.93 UNSUP-PA  120.5 ± 9.2 116.6 ± 10.6 -3.9 ± 7.3 
SUP-PA  118.9 ± 13.0 115.3 ± 12.2 -3.6 ± 10.9 
Resting 
Diastolic Blood 
Pressure 
(mmHg) 
STEP  69.8 ± 8.5 67.9 ± 9.2 -1.9 ± 4.1  
0.66 
 
<0.01 
 
0.97 UNSUP-PA  71.8 ± 10.0 69.5 ± 7.4 -2.3 ± 4.4 
SUP-PA  72.7 ± 8.5 70.3 ± 9.5 -2.4 ± 6.1 
Treadmill Time 
(min) 
STEP  11.1 ± 3.8 11.9 ± 3.7 0.8 ± 2.1  
0.07 
 
<0.001 
 
0.41 UNSUP-PA  8.4 ± 2.9 9.4 ± 3.7 1.0 ± 2.0 
SUP-PA  8.2 ± 3.3 9.8 ± 4.1 1.7 ± 1.7 
Peak VO2 
(ml/kg/min) 
STEP  27.9 ± 5.5 29.2 ± 6.0 1.3 ± 2.4  
0.26 
 
<0.001 
 
0.01 UNSUP-PA  23.9 ± 4.5 27.7 ± 5.7 3.8 ± 3.2 
SUP-PA  24.4 ± 4.2 28.2 ± 4.9 3.8 ± 1.6 
Peak VO2 
(L/min) 
STEP  2.43 ± 0.56 2.39 ± 0.60 -0.04 ± 0.19  
0.44 
 
<0.001 
 
<0.01 UNSUP-PA  2.08 ± 0.52 2.25 ± 0.54 0.17 ± 0.24 
SUP-PA  2.09 ± 0.59 2.31 ± 0.71 0.22 ± 0.23 
4.7 CHANGE IN BLOOD PRESSURE AND RESTING HEART RATE 
There were significant reductions in resting heart rate, resting systolic blood pressure, and 
diastolic blood pressure over time for STEP, UNSUP-PA, and SUP-PA (p<0.001). However, there 
was not a significant group effect or group X time interaction for any of these variables. Resting 
heart rate was reduced in STEP (-3.5 ± 10.3 beats/min), UNSUP-PA (-6.2 ± 9.7 beats/min) and 
SUP-PA (-11.3 ± 8.7 beats/min). Resting systolic blood pressure was reduced in STEP (-2.8 ± 7.6 
mmHg), UNSUP-PA (-3.9 ± 7.3 mmHg) and SUP-PA (-3.6 ± 10.9 mmHg), and diastolic blood 
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 pressure was reduced in STEP (-1.9 ± 4.1 mmHg), UNSUP-PA (-2.3 ± 4.4 mmHg) and SUP-PA 
(-2.4 ± 6.1 mmHg). Data are presented in Table 12.  
4.8 CHANGE IN ENERGY INTAKE AND EATING BEHAVIORS 
There was a significant reduction in caloric intake for STEP (-388 ± 1056), UNSUP-PA (-
431 ± 953), and SUP-PA (-561 ± 862) over the 12-week intervention (p<0.001). There were no 
significant differences between groups (p=0.51) and there was no significant group by time 
interaction (p=0.88). Consumption of fats, carbohydrates and proteins (grams) was significantly 
reduced over the 12-week intervention (p=0.001, p<0.001, p=0.002 respectively). There were no 
changes in percent of intake from fat (p=0.34) or percent of intake from carbohydrates (p=0.75), 
however, there was a significant increase in percent protein (p<0.01) for STEP (1.7 ± 3.8%), 
UNSUP-PA (1.0 ± 2.2%), and SUP-PA (1.2 ± 2.9). There were no group by time interactions for 
percent fat (p=0.64), percent carbohydrate (p=0.47), and percent protein (p=0.74). Data are 
presented in Table 13.  
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 Table 13. Change in Dietary Intake 
  P-Values 
Outcome Group Baseline 12 Weeks Change Group Time Group X 
Time 
Energy Intake 
(kcal/day) 
STEP (N=17) 1885 ± 905 1497 ± 522 -388 ± 1056  
 
0.51 
 
 
<0.01 
 
 
0.88 
UNSUP-PA (N=16) 1773 ± 922 1342 ± 438 -431 ± 953 
SUP-PA (N=14)  1774 ± 679 1214 ± 370 -561 ± 862 
Dietary Fat 
(grams) 
 
STEP 76.0 ± 39.4  54.4 ± 20.8  -21.5 ± 32.3   
 
0.89 
 
 
<0.01 
 
 
0.79 
UNSUP-PA 74.3 ± 51.5 48.6 ± 17.8  -25.7 ± 54.7  
SUP-PA 69.5 ± 30.7  53.5  ± 18.8  -15.9 ± 22.4  
Dietary Carbohydrates  
(grams) 
STEP 216.6 ± 107.3  151.2 ± 66.8 -65.4 ± 80.6   
 
0.79 
 
 
<0.001 
 
 
0.66 
UNSUP-PA 194.3 ± 84.6 153.7 ± 64.0  -40.7 ± 85.2  
SUP-PA 215.8 ± 95.6  167.8 ± 47.0  -48.0 ± 72.9 
Dietary Protein  
(grams) 
 
STEP 75.5 ± 36.6  60.3 ± 24.7  -15.2 ± 23.9  
 
0.73 
 
 
<0.01 
 
 
0.85 
UNSUP-PA 69.5 ± 40.3  53.0 ± 19.2  -16.4 ± 40.5 
SUP-PA 71.7± 28.2 61.3 ± 19.8  -10.4 ± 20.5  
% Intake From Fat STEP 36.6 ± 5.0 36.9 ± 7.0 0.3 ± 5.8  
0.48 
 
0.34 
 
0.64 UNSUP-PA 37.1 ± 8.1 35.1 ± 5.7 -2.0 ± 8.4 
SUP-PA 35.0 ± 6.6 33.9 ± 5.1 -1.1 ± 6.1  
% Intake From Carb STEP 46.8 ± 7.4 44.7 ± 7.4 -2.1 ± 6.7  
0.51 
 
0.75 
 
0.47 UNSUP-PA 47.0 ± 9.6 48.2 ± 6.3 1.2 ± 8.5 
SUP-PA 48.6 ± 8.8 48.5 ± 7.2 -0.1 ± 7.5    
% Intake From Protein STEP 16.6 ± 3.7 18.3 ± 4.6 1.7 ± 3.8  
0.58 
 
<0.01 
 
0.74 UNSUP-PA 15.9 ± 2.3 16.9 ± 2.1 1.0 ± 2.2 
 SUP-PA 16.4 ± 2.9 17.6 ± 3.1 1.2 ± 2.9  
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 There was a significant improvement in Eating Behavior Inventory scores for STEP (5.8 ± 
10.9), UNSUP-PA (13.1 ± 8.4), and SUP-PA (11.9 ± 10.3) over the 12-week intervention 
(p<0.001). There was no significant group effect (p=0.48) or group by time interaction effect 
(p=0.09). For the Three Factor Eating Questionnaire, there was a significant time effect on 
Restraint (p<0.001), Disinhibition (p<0.001), and Hunger (p<0.001). There was no group effect or 
group by time effect on Restraint (group: p=0.30, group x time: p=0.94), Disinhibition (group: 
p=0.70, group x time: p=0.80), and Hunger (group: p=0.74, group x time: p=0.85). Results are 
shown in Table 14. 
 
 Table 14. Change in Eating Behaviors 
  P-Values 
Outcome Group Baseline 12 Weeks Change Group Time Group 
X 
Time 
Eating 
Behavior 
Inventory 
STEP (N=17) 62.6 ± 11.7 68.4 ± 12.8 5.8 ± 10.9  
0.48 
 
<0.001 
 
0.09 UNSUP-PA (N=16) 57.6 ± 5.2 70.7 ± 8.1 13.1 ± 8.4 
SUP-PA (N=16)  61.5 ± 6.9 73.4 ± 7.4 11.9 ± 10.3 
Restraint STEP (N=17) 12.8 ± 2.4 15.2 ± 4.5 2.4 ± 4.5  
0.30 
 
<0.001 
 
0.94 UNSUP-PA (N=16) 12.6 ± 1.9 15.4 ± 4.3 2.8 ± 3.8 
SUP-PA (N=16)  13.8 ± 2.2 16.6 ± 2.3 2.8 ± 3.3 
Disinhibition STEP (N=17) 10.9 ± 1.0 5.6 ± 3.3 -5.3 ± 2.7  
0.70 
 
<0.001 
 
0.80 UNSUP-PA (N=16) 10.6 ± 1.0 5.8 ± 4.4 -4.8 ± 4.3 
SUP-PA (N=16)  11.1 ± 0.9 6.5 ± 3.2 -4.6 ± 2.6 
Hunger STEP (N=17) 12.1 ± 1.1 3.5 ± 2.9 -8.6 ± 2.8  
0.74 
 
<0.001 
 
0.85 UNSUP-PA (N=16) 11.8 ± 1.0 2.9 ± 2.4 -8.9 ± 2.0 
SUP-PA (N=16)  11.9 ± 1.0 3.3 ± 2.8 -8.4 ± 2.7 
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 4.9 CHANGE IN PHYSICAL ACTIVITY SELF-EFFICACY 
There was no significant improvement in physical activity self-efficacy scores for STEP 
UNSUP-PA, and SUP-PA over the 12-week intervention (p=0.14). There was no group effect 
(p=0.69) or group X time interaction (p=0.43). There was no significant improvement for 
perceived physical activity self-efficacy over the next 3 months for STEP, UNSUP-PA, and SUP-
PA over the 12-week intervention (p=0.95). There was also no group (p=0.66) or group by time 
interaction (p=0.15) for perceived physical activity self-efficacy over the next three months. 
There were no significant changes in perceived self-efficacy to walk 1 mile over the next 
3 months, or perceived self-efficacy to exercise in a gym setting over the next 3 months.  There 
was a significant increase in perceived self-efficacy to walk 1 mile briskly over the next 3 months 
for STEP, UNSUP-PA, and SUP-PA over the 12-week intervention (p=0.02).  There was no 
significant group effect (p=0.08) or group by time interaction effect (p=0.13) in perceived self-
efficacy to walk 1 mile briskly over the next 3 months.   
There was a group effect for perceived self-efficacy to achieve the prescribed physical 
activity goal over the next 3 months at baseline (p=0.04). Post hoc analyses with Bonferroni 
adjustment demonstrated that STEP was significantly different compared to UNSUP-PA (p=0.01) 
with no other differences between groups. (STEP vs. SUP-PA: p=0.125, UNSUP-PA vs. SUP-PA: 
p=1.00). There was no time effect (p=0.78) or group by time interaction (p=0.51) for perceived 
self-efficacy to achieve the exercise goal over the next 3 months. Data are presented in Table 15.
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 Table 15. Change in Physical Activity Self-Efficacy and Future Self-Efficacy 
  P-Values 
Outcome Group Baseline 12 Weeks Change Group Time Group 
X 
Time 
Physical Activity Self-Efficacy-
Total 
STEP (N=17) 16.5 ± 3.3 16.4 ± 4.0 -0.1 ± 4.0  
0.69 
 
0.14 
 
0.43 UNSUP-PA (N=16) 15.3 ± 3.8 16.9 ± 5.0 1.6 ± 3.1 
SUP-PA (N=16)  15.0 ± 3.8 16.0 ± 2.7 1.0 ± 4.2 
Perceived Physical Activity Self-
Efficacy over the next 3 Months-
Total 
STEP (N=17) 18.1 ± 3.2 16.9 ± 3.6 -1.2 ± 4.5  
0.66 
 
0.95 
 
0.15 UNSUP-PA (N=16) 15.8 ± 4.0 17.4 ± 5.0 1.6 ± 3.1 
SUP-PA (N=16)  17.8 ± 3.7 17.3 ± 3.6 -0.5 ± 4.5 
Perceived Self-Efficacy to 
Walk 1-mile over the next 3 
Months 
STEP (N=17) 4.88 ± 0.33 4.88 ± 0.33 0.00 ± 0.35  
0.25 
 
0.53 
 
0.41 UNSUP-PA (N=16) 4.75 ±  0.58 4.69 ± 0.87 -0.06 ± 0.93 
SUP-PA (N=16)  4.50 ± 0.63 4.75 ± 0.45 0.25 ± 0.68 
Perceived Self-Efficacy to 
Walk 1-mile Briskly over the 
next 3 Months 
STEP (N=17) 4.65 ± 0.61 4.82 ± 0.53 0.17 ± 0.53  
0.08 
 
0.02 
 
0.13 UNSUP-PA (N=16) 4.50 ± 0.82 4.56 ± 0.89 0.06 ± 0.93 
SUP-PA (N=16)  3.87 ± 1.09 4.50 ± 0.73 0.63 ± 0.96 
Perceived Self-Efficacy to 
Exercise in the Gym over the 
next 3 Months 
STEP (N=17) 4.53 ± 0.87 4.41 ± 1.06 -0.12 ± 0.70  
0.80 
 
0.45 
 
0.24 UNSUP-PA (N=16) 4.38 ± 1.03 4.38 ± 0.96 0.00 ± 1.15 
SUP-PA (N=16)  4.06 ± 0.93 4.50 ± 0.82 0.44 ± 1.03 
Perceived Self-Efficacy to 
Achieve Physical Activity 
Goal over the next 3 Months 
STEP (N=17) 4.65 ± 0.49 4.47 ± 0.72 -0.18 ± 0.81  
0.04 
 
0.78 
 
0.51 UNSUP-PA (N=16) 3.94 ± 1.00 4.12 ± 1.20 0.18 ± 0.98 
SUP-PA (N=16)  4.06 ± 0.77 3.94 ± 0.68 -0.12 ± 1.09 
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 4.10 CHANGE IN EXERCISE EXPECTATIONS AND BARRIERS  
There was no significant change in overall expectations of exercise for STEP, UNSUP-PA, 
SUP-PA (p=0.08), and there was no significant group effect (p=0.35) or group X time interaction 
(p=0.07). In addition there were no significant changes in psychological (p=0.17), health (p=0.09), 
and image (p=0.17) expectations for all three treatment groups across the 12-week intervention. 
There were no group (psychological: p=0.77, image: p=0.19, health: p=0.12) or group by time 
interaction effects (psychological: p=0.19, image: p=0.08, p=0.12) for psychological, image and 
health expectations. 
There were significant reductions in the scores for effort barriers’ (p<0.001) and overall 
barriers (p<0.001) for STEP, UNSUP-PA, and SUP-PA over the 12-week intervention. There were 
no significant group effects (effort: p=0.60; Overall: p=0.51) or group by time interactions for 
either of these variables (effort: p=0.70; Overall: p=0.88).  There were no significant changes in 
time or obstacle barriers over the 12 week intervention for any of the treatment groups.  Data are 
presented in Table 14. 
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 Table 16. Change in Expectations and Barriers to Exercise 
  P-Values 
Outcome Group Baseline 12 Weeks Change Group Time Group 
X Time 
 
Expectations 
(Benefits) 
 
       
     Psychological  STEP (N=17) 3.80 ± .69 3.69 ± .74 -0.11 ± 0.66  
0.77 
 
0.17 
 
0.19 UNSUP-PA (N=16) 3.56 ± .81 3.76 ± .97 0.20 ± 0.50 
SUP-PA (N=16)  3.43 ± .84 3.70 ± .66 0.27 ± 0.68 
     Image  STEP (N=17) 4.41 ± .49 4.29 ± .67 -0.12 ± 0.52  
0.19 
 
0.09 
 
0.08 UNSUP-PA (N=16) 4.44 ± .63 4.64 ± .50 0.20 ± 0.40 
SUP-PA (N=16)  3.94 ± 1.01 4.34 ± .71 0.40 ± 0.94 
     Health STEP (N=17) 4.78 ± .35 4.69 ± .34 -0.09 ± 0.45  
0.12 
 
0.17 
 
0.14 UNSUP-PA (N=16) 4.60 ± .53 4.73 ± .49 0.13 ± 0.34 
SUP-PA (N=16)  4.21 ± 1.01 4.60 ± .57 0.39 ± 1.09 
     Overall STEP (N=17) 4.25 ± .41 4.14 ± .49 -0.11 ± 0.46  
0.35 
 
0.08 
 
0.07 UNSUP-PA (N=16) 4.11 ± .59 4.30 ± .60 0.19 ± 0.26 
SUP-PA (N=16)  3.79 ± .85 4.14 ± .54 0.35 ± 0.81 
 
Barriers 
 
       
     Time STEP (N=17) 3.33 ± 1.12 2.80 ± .95 -0.53 ± 0.87  
0.99 
 
0.11 
 
0.33 UNSUP-PA (N=16) 3.15 ± 1.22 3.02 ± 1.29 -0.13 ± 0.90 
SUP-PA (N=16)  3.08 ± 1.16 3.04 ± 1.03 -0.04 ± 1.20 
     Effort STEP (N=17) 2.66 ± .76 2.27 ± .82 -0.39 ± 0.70  
0.60 
 
<0.001 
 
0.51 UNSUP-PA (N=16) 2.80 ± .85 2.23 ± 1.13 -0.57 ± 0.80 
SUP-PA (N=16)  3.07 ± .73 2.38 ± .84 -0.69 ± 0.85 
     Obstacles STEP (N=17) 1.94 ± .56 1.81 ± .55 -0.13 ± 0.60  
0.64 
 
0.19 
 
0.63 UNSUP-PA (N=16) 1.98 ± .56 1.97 ± .82 -0.01 ± 0.76 
SUP-PA (N=16)  2.19 ± .74 1.92 ± .66 -0.27 ± 0.83 
     Overall STEP (N=17) 2.59 ± .61 2.26 ± .60 -0.33 ± 0.59  
0.70 
 
<0.001 
 
0.88 UNSUP-PA (N=16) 2.63 ± .75 2.33 ± .89 -0.30 ± 0.63 
SUP-PA (N=16)  2.80 ± .53 2.39 ± .63 -0.41 ± 0.71 
87 
 4.11 TREATMENT SATISFACTION 
Overall, 98% of the participants reported that they would recommend this weight 
management program to others. In addition, 90% of participants reported that they would 
recommend the physical activity portion of the program to others. Ninety-two percent of 
participants reported being somewhat satisfied or very satisfied with the weight management 
program and 86% reported being somewhat satisfied or very satisfied with the physical activity 
portion of the program. Eighty-eight percent of participants in STEP reported being somewhat 
satisfied or very satisfied with their progress, while 82% of UNSUP-PA were somewhat satisfied 
or very satisfied and 100% of SUP-PA were somewhat satisfied or very satisfied with their 
progress.  Treatment satisfaction data are reported in Table 17.
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 Table 17. Treatment Satisfaction 
Question Group Would 
Recommend 
Very 
Dissatisfied 
Somewhat 
Dissatisfied 
Somewhat 
Satisfied 
Very 
Satisfied 
Weight Management 
Program 
N, (%) 
STEP (N=17)  17, (100%) 1, (6%) 1, (6%) 2, (12%) 13, (76%) 
UNSUP-PA (N=16) 15, (94%) 1, (6%) 2, (13%) 3, (19%) 11, (69%) 
SUP-PA (N=16)  16, (100%) 1, (6%) 0, (0%) 3, (19%) 13, (81%) 
Physical Activity  
Program 
N, (%) 
STEP  15, (88%) 1, (6%)  2, (12%) 5, (29%) 9, (53%) 
UNSUP-PA  14, (88%) 2, (13%) 0, (0%) 3, (19%) 11, (69%) 
SUP-PA  15, (94%) 0, (0%) 2, (13%) 4, (25%) 10, (63%) 
Satisfaction with 
Progress 
N, (%) 
STEP   1, (6%) 1, (6%) 2, (12%) 13, (76%) 
UNSUP-PA   1, (6%) 2 (13%) 3, (19%) 10, (63%) 
SUP-PA   0 0 8, (50%) 8, (50%) 
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 4.12 INTERVENTION PROCESS MEASURES 
Chi-square and one-way ANOVA’s were used to examine group attendance, and physical 
activity participation for SUP-PA, UNSUP-PA, and STEP. Group attendance rates were similar 
for STEP (96.8 ± 7.1%), UNSUP-PA (94.1 ± 22.2%), and SUP-PA (92.4 ± 10.8%) (p=0.66).  
SUP-PA engaged in 109 ± 49 minutes/week across the 12-week intervention with 9 
participants achieving ≥85% of the total minutes of exercise prescribed for the 12-week 
intervention. Intervention physical activity data are presented in Table 16. SUP-PA was prescribed 
3-5 days/week of physical activity in sessions of 10-60 minutes completed at an intensity of 60-
75% heart rate maximum. 97.2% of the heart rates taken were above the 60% heart rate threshold. 
Participants exercised on the treadmill (55%), stationary cycle (9.5%), elliptical (14.3%) and 
adaptive motion trainer (21.2%). Data are illustrated in Figure 9. Physical activity prescription and 
physical activity participation are illustrated in Figure 10.  
UNSUP-PA self-reported engaging in 170 ± 150 minutes/week of moderate-to-vigorous 
physical activity across the 12-week intervention according to weekly diaries. Individuals that 
failed to turn in a physical activity log book were counted as having zero minutes for that week of 
the intervention.  Twelve participants in UNSUP-PA achieved the physical activity prescription 
(defined as achieving ≥85% of the total minutes of exercise prescribed for the 12-week 
intervention). Data are illustrated in Figure 11. 
Adherence to the physical activity prescriptions was also analyzed based on diary data. 
Individuals that failed to turn in a physical activity log book were counted as having zero steps for 
that week of the intervention. STEP self-reported averaging 10,572 ± 2195 steps/day with 2916 ± 
1672 brisk steps/day across the 12-week intervention. Twelve participants in STEP achieved the 
total step/day physical activity prescription (defined as accumulating ≥85% of the prescribed 
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 amount of total steps for the 12-week intervention) and 14 participants regularly achieved the brisk 
step/day goal (defined as accumulating ≥85% of the prescribed amount of brisk steps for the 12-
week intervention). Data are illustrated in Figure 12 and 13. 
 
Figure 9. Supervised Exercise Equipment Use 
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Figure 10. Objectively Measured Physical Activity via Observation for SUP-PA across the Intervention 
 
Figure 11. Self-Reported Physical Activity via Diary for UNSUP-PA across the Intervention 
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Figure 12. Self-Reported Total Steps/Day via Diary for STEP across the Intervention 
 
Figure 13. Self-Reported Brisk Steps/Day via Diary for STEP across the Intervention 
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 Previous supervised exercise trials have been efficacy trials rather than effectiveness trials; 
thus, previous trials have only used data from individuals adhering to the physical activity 
prescription. To examine if a similar data analysis would change the outcomes of this study, we 
analyzed the data using only data from individuals who adhered to the physical activity 
prescription. Adherence was defined as completing 85% of the physical activity prescription or 
more. STEP had 12 adherers and 5 non-adherers, UNSUP-PA had 12 adherers and 4 non-adherers, 
and SUP-PA had 9 adherers and 7 non-adherers. When examining percent weight loss, there was 
a significant difference between adherers and non-adherers in STEP (p<0.001); however, there 
were no differences between adherers and non-adherers in UNSUP-PA (p=0.55) and SUP-PA 
(p=0.56). When examining cardiorespiratory fitness, there was a difference between adherers and 
non-adherers in STEP (p=0.03); however, there were no differences between adherers and non-
adherers in UNSUP-PA (p=0.92) and SUP-PA (p=0.99). Data are illustrated in Figures 14 and 15. 
 
Figure 14. Percent Weight Loss by Adherers and Non-Adherers 
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Figure 15. Change in Fitness by Adherers and Non-Adherers
-1
-0.5
0
0.5
1
1.5
2
2.5
3
3.5
4
4.5
STEP UNSUP-PA SUP-PA
Ch
an
ge
 in
 V
O
2 
(m
l/k
g/
m
in
)
Adherers Non-Adherers
p=0.99 p=0.92 p=0.03 
95 
 5.0  DISCUSSION 
This study was conducted to compare the effectiveness of a supervised physical activity 
program and two unsupervised physical activity programs combined with a standard behavioral 
weight loss intervention across 12-weeks in adults who were overweight or obese. Previous 
comparisons of supervised and unsupervised physical activity programs during weight loss 
interventions have yielded inconsistent changes in weight, fitness and physical activity.19,21,22,24,36 
Moreover, previous trials have lacked a comprehensive assessment of outcomes including 
objective measures of physical activity. The current investigation prescribed similar doses of 
physical activity to be completed in a supervised setting or an unsupervised setting to distinguish 
if physical activity behaviors and physiological responses would be different between the various 
interventions.  
5.1 PARTICIPANT RETENTION 
Forty-nine out of 52 (94.2%) participants completed the baseline and 12-week assessments. 
Attrition of one participant per group was observed. This level of retention is comparable or better 
than previous trials utilizing supervised exercise.22,24,27,91,190 Attrition rates are typically higher in 
trials utilizing supervised exercise compared to studies prescribing unsupervised physical 
activity.27,175,190,191 In a 12-week study utilizing a behavioral weight management program and 
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 supervised exercise, Verba and colleagues reported 75% retention.190 Perri et al. reported 81.6% 
retention over a 6-month behavioral weight loss intervention with supervised exercise, concluding 
that individuals completing supervised exercise were more likely to drop-out compared to 
individuals completing unsupervised physical activity.22 It is possible that supervised exercise is 
inconvenient for participants and increases individual time commitment leading to increased rates 
of attrition; however, the current study showed equal rates of attrition across all groups.  
5.2 CHANGE IN PHYSICAL ACTIVITY 
The primary aim of this study was to compare changes in MVPA completed in bouts of ≥ 
10 minutes between STEP, UNSUP-PA, and SUP-PA across the 12-week intervention. This 
investigation demonstrated that STEP, UNSUP-PA, and SUP-PA were successful at increasing 
levels of MVPA completed in bouts of ≥ 10 minutes with no differences between groups (see 
Figure 7). It was hypothesized that SUP-PA would engage in the highest levels of MVPA 
compared to UNSUP-PA and STEP because supervised physical activity is considered the gold-
standard for prescribing physical activity within research settings and all of SUP-PA’s physical 
activity was supervised by an exercise physiologist to confirm proper exercise intensity. However, 
the current study demonstrated that prescribing physical activity that is unsupervised can be just 
as effective for increasing MVPA completed in bouts of ≥ 10 minutes.  
MVPA, and more specifically MVPA completed in bouts of ≥ 10 minutes, are associated 
with improved long-term weight loss and weight maintenance.13,14,137 While this study was only 
12-weeks in duration, it is evident that all three physical activity prescriptions increased 
objectively measured MVPA. Previous trials comparing supervised and unsupervised programs 
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 within a weight loss trial did not objectively measure physical activity, 21-24 so the current study 
offers a unique contribution to the literature. However, it is unclear if the MVPA observed in this 
study would have continued over a longer period of time and further investigation is warranted. 
To our knowledge this is one of the first studies to also assess changes in other forms of 
physical activity (MVPA, LPA, and SED) using objective measures when comparing a supervised 
program and an unsupervised physical activity program, specifically within a behavioral weight 
management program. Hypotheses related to physical activity behavior in this study were based 
on the ActivityStat hypothesis.35 Because the physical activity prescription for SUP-PA 
specifically targeted MVPA completed in bouts of ≥ 10 minutes, it was hypothesized that SUP-
PA would not have increases in LPA. Moreover, it was hypothesized that UNSUP-PA and STEP 
would increase LPA because of the lifestyle approach of these interventions. However, STEP, 
UNSUP-PA, and SUP-PA all had favorable increases in LPA across the 12-week intervention with 
no differences between groups. LPA is positively associated with improved weight loss 
outcomes.137 These results indicate that during 12-week weight loss intervention, all three physical 
activity prescriptions produced similar increases LPA, which may promote future weight loss 
maintenance. 
Sedentary behavior (SED) is another component from the physical activity spectrum that 
may affect weight loss outcomes. SED is associated with obesity and several cardiometabolic risk 
factors.87,90,192,193 A previous trial conducted by Jakicic et al. focused on a calorie restricted diet 
and increased unsupervised MVPA, SED was also decreased.100 In the current trial, it was 
hypothesized that SUP-PA may compensate for the increased structured physical activity by 
increasing SED. This aligned with the ActivityStat hypothesis.35 However, objective measures of 
SED demonstrated that STEP, UNSUP-PA, and SUP-PA all decreased SED similarly. It is unclear 
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 if these decreases in SED, independent of other components of physical activity impacted weight 
loss or other outcomes assessed. 
This study utilized a novel steps/day prescription utilizing a total steps/day count and a 
brisk steps/day recommendation. This recommendation was based on a secondary data analysis by 
Creasy et al.178 finding that people who successfully lost weight during a behavioral weight loss 
intervention were taking approximately 10,000 steps/day with 2,500 to 3,000 brisk steps/day. 
Based upon this finding, participants in the STEP group were prescribed 10,000 steps/day with 
2,500 brisk steps/day completed in bouts of ≥ 10 minutes. Using a steps/day recommendation may 
be more manageable for overweight and obese adults who were previously inactive. In addition, 
giving a daily step goal may positively promote behavior change daily. Objective physical activity 
data confirmed that STEP closely paralleled these recommendations throughout the 12-week 
intervention. In addition, other measures of physical activity were similar between STEP and the 
other two treatment groups. These results demonstrate that using a steps/day recommendation 
elicits similar changes in physical activity behaviors compared to unsupervised physical activity 
prescribed in minutes/day and a supervised exercise program prescribed in minutes/day. Therefore, 
future programs may utilize a similar steps/day recommendation to decrease the potential costs 
and burden of a supervised program. 
Overall, all three treatment groups increased physical activity as prescribed during the 12-
week intervention. Objectively measured physical activity confirmed that individuals were 
following the physical activity recommendations. There were no differences in the change in 
physical activity behaviors between the three treatment groups. Therefore, using unsupervised 
physical activity programs may be advantageous considering supervised programs can be 
burdensome, expensive, and lack generalizability. It is also important to note that UNSUP-PA 
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 increased MVPA without the use of any activity device and STEP increased MVPA using only a 
basic pedometer. Both unsupervised groups were anchored to moderate intensity physical activity 
using ratings of perceived exertion. Thus, when anchored properly and combined with a strong 
behavioral component, participants engaging in a behavioral weight loss intervention were able to 
increase physical activity without the need for close monitoring from study staff. Future trials and 
investigations may benefit from prescribing physical activity in a similar, unsupervised manner. 
Because all three treatment groups were successful at increasing positive physical activity, this 
gives researchers, programs, and institutions options to include physical activity with the context 
of a behavioral weight management program. 
5.3 CHANGE IN WEIGHT, ANTHROPOMETRICS, AND BODY COMPOSITION  
5.3.1 Change in Weight 
This investigation demonstrated that STEP, UNSUP-PA, and SUP-PA successfully lost 
weight when physical activity was combined with a comprehensive weight management 
intervention (STEP: -5.3 ± 3.6 kg, UNSUP-PA: -5.1 ± 3.3 kg, SUP-PA: -3.8 ± 3.0 kg) with no 
differences between groups. These findings suggest that all three interventions are comparable for 
producing weight loss. This finding was contrary to the original hypothesis that suggested that 
SUP-PA would result in the most weight loss compared to UNSUP-PA and STEP.  
Weight losses in this trial are comparable to previous behavioral weight loss interventions 
lasting 3-4 months in duration.22-24,91 Results of the current study closely parallel the findings of 
Craighead and Blum which found that combining a behavioral weight management program with 
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 supervised exercise induced a weight loss of 5.0 ± 1.2 kg, while contracted exercise (unsupervised) 
induced a weight loss of 3.8 ± 1.4 kg.23 The results of the study conducted by Craighead and Blum 
were limited because no formal physical activity participation data were reported.23  
The weight loss results of the current study are also similar to the 12-week weight losses 
observed from Verba and colleagues,190 and the 3-month weight losses in observed in a study 
conducted by Perri et al.22 Both of these previous trials utilized supervised exercise and a strong 
behavioral weight management program. 
Attainment of 5% weight loss is a reasonable goal for interventions targeting weight loss;189 
in addition, 5% weight loss is associated reduced weight-related health risk.14 When further 
separating treatment groups into of >5% weight loss and <5% weight loss, STEP and UNSUP-PA 
had significantly more individuals achieving 5% weight loss compared to SUP-PA. It is unclear 
why STEP and UNSUP-PA had higher rates of individuals achieving 5% weight loss because 
physical activity (energy expenditure) and energy intake were not different between groups. 
Nonetheless, it is intriguing that both UNSUP-PA and STEP had higher achievement of this goal, 
and further investigation may be warranted. 
Overall, the results of this study demonstrate that when combined with a standard 
behavioral weight loss intervention prescribing supervised physical activity in minutes/week, 
unsupervised physical activity in minutes/week, and unsupervised physical activity in steps/day 
produced similar amounts of weight loss. Thus, all three physical activity programs are feasible 
options for promoting weight loss when combined with a standard behavioral weight management 
program. 
101 
 5.3.2 Change in Body Composition and Anthropometrics 
Across the 12-week intervention STEP, UNSUP-PA, and SUP-PA lost similar amounts of 
fat tissue. These losses in fat mass were similar to a previous study of similar duration utilizing 
supervised exercise and a SBWP.190 During behavioral weight loss interventions, individuals lose 
predominantly fat mass; however, some weight loss is due to losses in lean mass.194 Trials have 
attempted to retain lean mass through aerobic exercise and resistance training; however, most 
individuals lose a small amount (13-28%) of lean mass.46,194 In the current trial, UNSUP-PA and 
SUP-PA lost approximately 1 kg of lean mass while SUP-PA retained lean mass (p=0.06). Janssen 
et al. showed that supervised aerobic exercise coupled with a calorie restricted diet was the most 
efficacious strategy for retaining lean tissue compared to diet only and resistance training plus 
diet.46 However, objectively measures physical activity did not differ by group in the current trial; 
thus, it is unclear why SUP-PA retained lean mass. A possible explanation is SUP-PA was coming 
to the PAWMRC 3-4 days per week and may have perceived that they were putting forth a high 
amount of exercise effort in the trial. Therefore, SUP-PA may not have adhered as closely to the 
dietary recommendations and relied heavily on the caloric expenditure of the exercise to promote 
weight loss; however, this was not supported by the energy intake data collected. Potentially a 
longer trial with objective measures of dietary intake are needed to help elucidate why supervised 
physical activity would promote lean mass retention compared to the unsupervised programs. 
Overall, the reasons why SUP-PA retained lean mass compared to UNSUP-PA and STEP remain 
uncertain and further investigation may be warranted.  
STEP, UNSUP-PA, and SUP-PA reduced waist circumference (umbilicus and iliac crest) 
and hip circumference during the 12-week intervention with no differences between the groups. 
Changes in these anthropometric measurements are similar to other weight loss trials of similar 
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 duration.190,191,195 It was hypothesized that SUP-PA would have the most favorable changes in 
anthropometric measures, however, STEP and UNSUP-PA had similar reductions in waist and hip 
circumference measures. It is possible that we did not see this effect because the intervention was 
too short and the diet blunted the effects of the physical activity on visceral adiposity. A longer 
trial may be needed to allow enough time to differentiate the benefits of the MVPA versus the 
effects of weight loss alone on visceral fat; however, in this 12-week trial supervised physical 
activity and unsupervised physical activity resulted in similar changes in anthropometrics. 
5.4 CHANGES IN PHYSIOLOGICAL VARIABLES 
5.4.1 Changes in Cardiorespiratory Fitness 
A commonly reported benefit of increased physical activity is increased cardiorespiratory 
fitness (i.e., functional capacity). The results of this study demonstrate that STEP, UNSUP-PA, 
and SUP-PA all improved cardiorespiratory fitness during the 12-week intervention (STEP: 1.3 ± 
2.4 ml/kg/min, UNSUP-PA: 3.8 ± 3.2 ml/kg/min, SUP-PA: 3.8 ± 1.6 ml/kg/min). Both UNSUP-
PA and SUP-PA improved cardiorespiratory fitness more than STEP in response to the 
intervention. Because weight loss can potentially confound increases in relative oxygen 
consumption, data were also analyzed to examine changes in peak absolute oxygen consumption 
from the submaximal exercise test. Based on this analysis, SUP-PA and UNSUP-PA improved 
fitness while there was no change in fitness for STEP (SUP-PA: 0.22 ± 0.23 L/min, UNSUP-PA: 
0.17 ± 0.24 L/min, STEP: -0.04 ± 0.19). There were no differences between SUP-PA and UNSUP-
PA in either analysis. Thus, it appears that both unsupervised and supervised physical activity 
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 programs prescribed in minutes/week result in comparable increases in fitness. Perri et al. found 
that supervised exercise and home-based exercise improved relative oxygen consumption after 6 
months of training (Supervised: 3.71 ml/kg/min, Unsupervised: 3.91 ml/kg/min).22 In addition, 
Perri et al. found that absolute oxygen consumption improved in both the supervised and 
unsupervised physical activity programs after 6 months of training. These results mirror the results 
of the current study.  
Previously, step/day recommendations have not resulted in increased cardiorespiratory 
fitness.26 The current study attempted to increase cardiorespiratory fitness by utilizing a brisk 
step/day recommendation. While STEP did improve relative oxygen consumption, these 
improvements may partially be attributed to the weight loss because absolute oxygen consumption 
did not change. The reason why STEP did not improve fitness cannot be explained by differences 
in physical activity in this study and therefore warrants further investigation. However, this does 
suggest that there may be a blunted increase in absolute fitness when activity is prescribed as 
steps/day rather than minutes of MVPA/week. 
Overall, the current study was successful at increasing cardiorespiratory fitness. This has 
important health implications because cardiorespiratory fitness is significantly associated with 
reduced risk of cardiovascular disease and mortality.56-59 Moreover fitness is associated with 
improved health even in the presence of overweight and obesity. Contrary to our hypothesis, 
UNSUP-PA was able increase fitness at a similar magnitude compared to SUP-PA. This finding 
has important research and clinical implications. The current study demonstrates that given the 
proper behavioral intervention and physical activity prescription unsupervised physical activity 
can be just as beneficial as supervised physical activity for previously inactive overweight and 
obese adults.  
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 5.4.2 Changes in Resting Heart Rate and Blood Pressure 
STEP, UNSUP-PA, and SUP-PA all decreased resting heart rate during the 12-week 
intervention. It was hypothesized that SUP-PA would have a greater decrease in resting heart rate 
compared to UNSUP-PA and STEP; however, there were no differences between the groups. This 
is not surprising considering all three groups had similar changes in physical activity across the 
12-week intervention. 
STEP, UNSUP-PA, and SUP-PA decreased systolic and diastolic blood pressure over the 
course of the weight loss intervention. It was hypothesized that SUP-PA would have a greater 
decrease in resting blood pressure compared to UNSUP-PA and STEP; however, there were no 
differences between the groups.  Decreases in systolic blood pressure were similar to other 
behavioral weight loss interventions utilizing calorie-restricted diets and physical activity.19,21,196 
Because obesity is a risk factor for elevated blood pressure,175 it is important to emphasize that all 
three physical activity prescriptions lowered diastolic and systolic blood pressure. Therefore, using 
an unsupervised physical activity prescription coupled with a behavioral weight management 
program with a dietary component is a potential strategy to reduce resting blood pressure. 
5.5 CHANGES IN DIETARY INTAKE AND EATING BEHAVIORS 
Energy intake and eating behaviors were a critical component of this the behavioral 
intervention delivered in this study. All three groups significantly reduced caloric intake across the 
12-week intervention. On average groups reduced energy intake by ~400 to 500 kcals/day. 
Changes in energy intake were similar to previous trials of similar duration.190,196 In this study, 
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 participants were prescribed a reduced calorie diet (1200-1800 kcals/day) with 20-30% of intake 
from fat. This prescription is similar other studies utilizing calorie-restriction and physical to 
promote weight loss.175,190,196 All three groups significantly reduced fat, carbohydrate, and protein 
intake across the 12-week intervention. However, percent change in macronutrient content was 
only significant for protein, which increased during the intervention. Relative changes in 
macronutrient content were similar to those reported in a study conducted by Rogers et al.196 
Changes in macronutrient intake were similar across all three treatment groups. By design, STEP, 
UNSUP-PA, and SUP-PA were given the same dietary recommendations and delivered the same 
weekly behavioral lessons. Thus, it is not surprising that all three groups had similar changes in 
energy intake and macronutrient intake. 
The behavioral weight loss intervention also focused on improving eating behaviors that 
are associated with long-term weight loss success. Improvements in eating behaviors were similar 
as measured by the Eating Behavior Inventory (EBI) across all three treatment groups. 
Improvements in EBI scores were similar compared to Rogers et al., which utilized a similar 3-
month behavioral weight loss intervention.196  
Furthermore, eating behaviors as measured by the Three Factor Eating Questionnaire 
improved similarly across all three groups. All three groups improved dietary restraint, decreased 
disinhibition, and decreased hunger as expected with a behavioral weight loss intervention.197,198 
Increased cognitive dietary restraint and reduced disinhibited eating are associated during weight 
loss treatment are associated with improved weight loss and weight maintenance.198 Therefore, the 
changes in the current study are indicative of long-term success. However, it is unclear if these 
changes would have persisted in a longer trial, and further investigation is warranted.  
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 5.6 PROCESS MEASURES 
All three groups had greater than 90% attendance to the weekly intervention meetings over 
the course of the 12-weeks with no difference between groups which is similar to attendance 
reported by Verba et al.190  Perri et al. had approximately 80% adherence to the behavioral 
intervention (defined as attendance to more than 50% of intervention sessions).22 It was 
hypothesized in previous supervised exercise trials that also utilized a weekly group meeting, that 
the supervised exercise group was overburdened with the time commitment of the study.22 In the 
current study, this was not the case because SUP-PA attended just as many weekly group meetings 
as UNSUP-PA and STEP.  
Based on self-report, UNSUP-PA and STEP had high adherence to the physical activity 
prescription throughout the 12-week intervention. SUP-PA had a lower adherence rate; however, 
SUP-PA’s exercise sessions were confirmed via observation rather than self-report. It is possible 
that actual adherence rates were lower in UNSUP-PA and STEP. The current study attempted to 
quantify physical activity participation across the intervention by objectively monitoring physical 
activity at week 4, 8 and 12 using the SenseWear device. Objectively measured physical activity 
at these pre-determined time-points demonstrated that UNSUP-PA and STEP were adherent to the 
physical activity prescription. In addition, SUP-PA was engaging in more physical activity than 
just the supervised exercise sessions. Future trials utilizing unsupervised physical activity 
programs should also use some method to confirm adherence (e.g., physical activity monitors, 
heart rate monitors, or GPS). 
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 5.7 PHYSICAL ACTIVITY SELF-EFFICACY, EXPECTATIONS, AND BARRIERS 
It was hypothesized that physical activity self-efficacy would improve over the 12-week 
intervention and that STEP and UNSUP-PA would have higher increases in self-efficacy 
compared to SUP-PA. However, this study failed to detect any significant changes in physical 
activity self-efficacy during the 12-week intervention. Previous literature has demonstrated that 
overweight women enrolling in a 6-month weight loss intervention utilizing unsupervised physical 
activity improved self-efficacy.199 The current study also failed to detect significant changes in 
perceived future physical activity self-efficacy. It is unclear why there were no improvements in 
physical activity self-efficacy during this 12-week intervention. 
 There were significant increases in perceived self-efficacy to continue to walk briskly 1-
mile across all three treatment groups with no differences between the groups. In addition there 
was a significant group effect for perceived self-efficacy to continue to achieve the physical 
activity goal over the next three months. Post-hoc analyses failed to detect the individual group 
differences; however, it appears that STEP and UNSUP-PA had higher reported self-efficacy 
compared to SUP-PA as hypothesized.  
Expected outcomes and barriers for physical activity were assessed using a previously 
validated questionnaire.200 There were no changes in the expected benefits for physical activity 
across the 12-week intervention with no differences between groups. Similarly, Gallagher et al. 
found that a 6-month behavioral weight loss intervention recommending unsupervised physical 
activity did not change image, health, or total benefits.199 In the current study there were significant 
decreases in effort and overall barriers during the 12-week intervention. Gallagher et al. found that 
time, effort, obstacle, and total barriers decreased in response to a 6-month weight loss program.199 
While the current study did not find significant decreases in all barriers, it is important to note that 
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 all reported barriers either decreased or remained unchanged during the 12-week intervention. It 
has been hypothesized that supervised exercise is burdensome and inconvenient; thus, one would 
expect SUP-PA to report a potential increase in barriers. Yet, this was not observed in the current 
study. Thus, supervised and unsupervised physical activity appear to produce similar perceived 
responses for expected outcomes and barriers for physical activity. 
5.8 CLINICAL IMPLICATIONS 
The results of this study have important implications for both research and clinical settings. 
Based on the findings of this study, unsupervised physical activity programs were just as effective 
as a supervised training program for increasing MVPA and promoting weight loss during a 
behavioral weight management program. In addition, when unsupervised physical activity was 
prescribed in minutes/week (i.e., similar to the supervised program) improvements in 
cardiorespiratory fitness were similar to supervised physical activity prescribed in minutes/day. 
This finding demonstrates that requiring individuals to complete supervised physical activity may 
not result in better outcomes compared to prescribing unsupervised physical activity.  
Supervised exercise trials offer numerous benefits for efficacy studies attempting to 
determine the effect of a controlled exercise dose on the desired outcome. However, supervised 
physical activity may be more expensive than unsupervised programs because of the need for 
additional staff to supervise the activity sessions and the need for facilities in which to conduct the 
supervised activity sessions. Supervised programs also lack generalizability outside of the research 
environment for participants who otherwise would not have access to a supervised program.  
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 Furthermore, the ActivityStat hypothesis suggests that requiring supervised exercise may 
inadvertently reduce non-exercise physical activity or increase sedentary time.35 Previous studies 
have failed to quantify compensation or changes in physical activity occurring outside of the 
supervised sessions that could either enhance or blunt the observed results. This study 
demonstrated that physical activity behaviors outside of the supervised exercise sessions were 
similar compared to the unsupervised groups with increased LPA and decreased SED. Ultimately 
the results of this study demonstrate that prescribing physical activity in a supervised or 
unsupervised manner elicits similar responses in physical activity, similar amounts of weight loss 
and similar improvements in fitness when coupled with a behavioral weight loss program. 
 Using a total steps/day goal along with a brisk step goal was just as effective as supervised 
exercise training at 60-75% heart rate maximum for increasing MVPA and eliciting weight loss. 
This finding has multiple public health implications. First, physical activity in the form of walking 
and brisk walking is an effective strategy for weight loss when enrolled in a behavioral weight 
management program. This message is important for all adults seeking to lose weight, but it may 
be even more important to individuals who have difficulty engaging in other forms of physical 
activity due to barriers such as lack of time, lack of resources, or for other various reasons.  
In addition, there is an abundance of consumer-based physical activity monitors that are 
commercially available. The wearable activity monitor market is projected to continue to grow 
over the next 5 years.201 These consumer-based monitors provide physical activity data in 
steps/day output, so the results of this study may be used to recommend physical activity 
prescriptions that are harmonious with these devices.  
There were no statistically significant differences in the change of MVPA between all three 
treatment groups. However, SUP-PA increased MVPA completed in bouts ≥ 10 minutes by 
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 approximately 30 min/wk more than UNSUP-PA and 70 min/wk more compared to STEP. While 
these differences did not induce differences in the physiological responses, these differences may 
be clinically significant. This study may have been underpowered to detect these differences. In 
addition, it is possible that physiological outcomes not measured in this study were impacted by 
these differences in MVPA. Future studies should be adequately powered to detect clinically 
significant differences in MVPA. Moreover, future studies should use additional physiological 
measures to examine the potentially meaningful effects of these differences in MVPA.   
Overall, supervised and unsupervised physical activity programs yielded similar results 
within a behavioral weight management program. Because supervised exercise programs are not 
always practical outside of research settings, it may be advantageous to utilize well-designed 
unsupervised programs which limit participant barriers and produce generalizable results.  
5.9 LIMITATIONS AND FUTURE DIRECTIONS 
Relatively few trials have been conducted to compare unsupervised physical activity to 
supervised physical activity during a behavioral weight loss intervention. While this trial adds to 
the current literature, the limitations of this study should be considered when interpreting the 
observed results.    
1. First, the current study was only 12-weeks in duration. Because the study was only 12-
weeks in duration, there may not have been enough time to detect a difference in weight 
loss between the groups. Previous literature has indicated that a calorie-restricted diet 
(creating a negative energy balance) is the primary cause of weight loss.32,33 While 
physical activity can contribute to weight loss, given that this trial was only 12 weeks 
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 in duration, physical activity may have had limited impact on the weight loss achieved. 
However, physical activity is strongly associated with weight maintenance. Thus, a 
longer trial would have been more conducive for comparing weight loss and weight 
maintenance.  
2. A priori power analyses were based on change in MVPA at week 12. This study did 
not have sufficient power to observe group X time interactions using repeated 
measures. Future studies should seek to recruit enough participants to examine 
interaction effects using repeated measures analyses. 
3. All three treatment groups were engaging in high amounts of physical activity at 
baseline (STEP: 35.4 ± 33.5 min/day, UNSUP-PA: 25.6 ± 36.0 min/day, SUP-PA: 28.0 
± 23.5 min/day). Participants self-reported not engaging in more than 60 minutes of 
structured physical activity per week during the initial eligibility screening. Thus, these 
participants must have been engaging in high amounts of lifestyle or occupational 
physical activity at the beginning of the study. Whether this influenced the results of 
this study is unclear and warrants further investigation. 
4. Because of the nature of supervised exercise, SUP-PA had to come to the Physical 
Activity and Weight Management Research Center (PAWMRC) at least three times 
per week to engage in supervised physical activity. In addition, SUP-PA came to the 
PAWMRC once a week for the behavioral intervention lesson. The increased burden 
of travel time may have detracted from the effectiveness of the intervention. However, 
attendance to the behavioral intervention was similar across all three groups, and 
adherence to the physical activity prescription was also similar across groups. 
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 Nonetheless, future studies may want to have multiple gym locations to make the 
supervised physical activity more convenient for participants.  
5. By design, it was not possible to control for total contact time across all three groups. 
SUP-PA had 3-4 additional contacts with study staff per week. To reduce the potential 
contamination of this additional contact time, study staff was instructed to not talk to 
SUP-PA about intervention-related material during the supervised exercise sessions. 
Future studies should also attempt control for the additional contact time associated 
with supervised exercise. 
6. Participants were prescribed 150 min/week of MVPA to match the physical activity 
guidelines. Future trials should also attempt to increase physical activity levels to 
parallel recommendations for long-term weight loss maintenance. It is recommended 
that individuals should be engaging in ~250 minutes of MVPA/week and this study 
only prescribed physical activity up to 150 minutes/week which may not be sufficient 
for weight maintenance.  
7. By design, UNSUP-PA and STEP were only able to provide self-report physical 
activity data each week in the form of an activity log book, while SUP-PA’s physical 
activity was directly observed by study staff. In order to minimize this limitation, the 
SenseWear device was worn at baseline week 4, week 8, and week 12 to measure 
physical activity objectively across all three groups throughout the intervention. These 
data were blinded to participants. Future studies should objectively measure physical 
activity throughout the intervention and provide participants with feedback using the 
objective data. 
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 8. Different components of physical activity were comprehensively assessed in this study 
including SED, LPA, and MVPA. However, it is unclear if the total activity patterns 
between STEP, UNSUP-PA, and SUP-PA were different leading to differences in total 
energy expenditure. Future trials focusing on weight change outcomes, should use 
doubly labeled water to measure total energy expenditure.  
9. The current study offers no explanation as to why STEP and UNSUP-PA had 
significantly more people achieve 5% weight loss. Future efforts should focus on 
examining individual level factors that may influence responses to these intervention 
approaches.  
10. This study did not perform any formal cost-effectiveness analyses; however, future 
trials should incorporate these data to help both clinical and research institutions to 
make informed decisions on these programs. 
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 5.10 SUMMARY 
In summary, this study showed that unsupervised physical activity programs can be as 
effective as a supervised program for increasing MVPA during a standard behavioral weight loss 
intervention for adults who are overweight or obese. The observed increases in MVPA were also 
accompanied by reductions in body weight, % body fat, resting heart rate, blood pressure, and 
increases in cardiorespiratory fitness when physical activity was combined with a standard 
behavioral weight loss intervention utilizing calorie restriction. These findings were observed 
regardless of intervention condition (STEP, SUP-PA, and UNSUP-PA).  While this trial was 
relatively short in duration, these results do offer initial evidence that unsupervised physical 
activity programs are just as successful at increasing physical activity compared to a supervised 
program.  
This suggests that there are a variety of options to prescribe physical activity during a 
standard behavioral weight loss intervention all of which can induce weight loss. Whether the 
results of this study will translate across populations or during a longer intervention period warrant 
further investigation. However, this study provides compelling evidence that unsupervised 
physical activity prescribed in minutes/week and an unsupervised physical activity program 
prescribed in steps/day can increase physical activity equally compared to a supervised physical 
activity program producing similar physiological improvements in adults who are overweight or 
obese. 
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 APPENDIX A 
PHYSICAL ACTIVITY DATA FOR INDIVIDUALS WITH ≥ 4 DAYS/WEEK ≥10 
HOURS/DAY
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 Table 18. Objectively Measured Physical Activity 
Outcome Groups Assessment Periods P-Values 
  Baseline 4 Weeks 8 Weeks 12 Weeks Time Group Time 
X 
Group 
Days of Wear Time STEP (N=17) 6.8 ± 0.6 6.9 ± 0.3 6.5 ± 1.1 6.8 ± 0.4  
0.09 
 
0.84 
 
0.71 UNSUP-PA (N=16) 6.7 ± 0.9 6.8 ± 0.4 6.4 ± 0.8 6.8 ± 0.4 
SUP-PA (N=12)  6.8 ± 0.6 6.9 ± 0.3 6.8 ± 0.5 6.6 ± 0.8 
Hours of Wear 
Time/Day 
STEP (N=17) 14.3 ± 1.7 14.5 ± 1.4 14.4 ± 1.6 14.6 ± 1.6  
0.44 
 
 
0.68 
 
0.90 UNSUP-PA (N=16) 14.8 ± 1.0 14.9 ± 0.9 14.6 ± 1.2 14.8 ± 1.2 
SUP-PA (N=12)  14.8 ± 1.3 15.0 ± 1.4 14.6 ± 1.1 14.7 ± 0.7 
SED (min/day) STEP (N=17) 585.6 ± 113.6 579.2 ± 105.4 521.8 ± 126.3 524.7 ± 110.0  
<0.001 
 
0.26 
 
0.99 UNSUP-PA (N=16) 638.3 ± 106.4 621.3 ± 88.2 586.5 ± 103.0 582.1 ± 112.7 
SUP-PA (N=12)  605.5 ± 91.8 589.5 ± 103.5 543.7 ± 84.8 547.4 ± 114.1 
LPA (min/day) 
 
STEP (N=17) 189.3 ± 57.9 210.2 ± 62.2 252.7 ± 82.0 259.0 ± 65.3  
<0.001 
 
0.31 
 
0.26 UNSUP-PA (N=16) 174.0 ± 67.7 180.2 ± 66.7 199.8 ± 62.8 231.1 ± 81.2 
SUP-PA (N=12)  205.1 ± 75.0 212.3 ± 69.2 231.7 ± 80.4 230.5 ± 80.7 
MVPA (min/day) 
 
STEP (N=17) 60.9 ± 45.2 71.5 ± 33.3 76.9 ± 41.0 75.3 ± 40.2  
<0.01 
 
0.79 
 
.099 UNSUP-PA (N=16) 49.2 ± 44.3 63.3 ± 49.8 67.6 ± 53.4 64.8 ± 50.2 
SUP-PA (N=12)  52.5 ± 42.6 72.3 ± 35.2 70.9 ± 47.2 73.2 ± 53.5 
Bouted MVPA 
(min/day) 
 
STEP (N=17) 35.4 ± 33.5 42.8 ± 23.6 51.2 ± 33.5 47.0 ± 28.2  
<0.001 
 
0.85 
 
0.92 UNSUP-PA (N=16) 25.6 ± 36.0 38.3 ± 42.6 46.1 ± 45.5 41.7 ± 44.5 
SUP-PA (N=12)  26.6 ± 23.6 43.5 ± 21.3 46.6 ± 29.9 50.1 ± 38.6 
Bouts of MVPA/Day  STEP (N=17) 1.6 ± 1.4 2.0 ± 1.1 2.1 ± 1.2 2.2 ± 1.3  
<0.01 
 
0.61 
 
0.94 UNSUP-PA (N=16) 1.2 ± 1.3 1.5 ± 1.2 1.8 ± 1.4 1.9 ± 1.6 
SUP-PA (N=12)  1.2 ± 1.2 1.7 ± 1.0 1.7 ± 1.1 1.9 ± 1.9 
Intensity of MVPA  
 
STEP (N=16) 4.4 ± 0.8 4.8 ± 0.9 4.9 ± 0.9 5.0 ± 1.1  
0.01 
 
0.45 
 
0.77 UNSUP-PA (N=11) 4.2 ± 0.6 4.7 ± 0.6 4.5 ± 0.8 4.5 ± 0.6 
SUP-PA (N=11)  4.2 ± 0.3 4.5 ± 0.6 4.6 ± 0.7 4.7 ± 0.8 
SED: Sedentary Time (<1.5 METs) 
LPA: Light-Intensity Physical Activity (≥1.5 METs to <3.0 METs)  
MVPA: Moderate-to-Vigorous Physical Activity (≥3.0 METs in bouts of ≥1 minute) 
Bouted MVPA: (≥3.0 METs in bouts of ≥10 minutes)  
Intensity of MVPA: (average METs/ physical activity bout ≥10 minutes)
117 
 APPENDIX B 
RECRUITMENT TELEPHONE SCREENING FORM
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 RECRUITMENT FORM:  
 
 
Thank you for your interest in our program.  My name is __________ and I am a 
student/staff member in the Department of Health and Physical Activity at the University of 
Pittsburgh. I would briefly like to tell you about this research program. 
 
 
Procedure for Describing the Study and Obtaining Verbal Consent to Conduct the 
Telephone Screen:  A description of the study will be read to participants, and this 
description includes important components of the informed consent process (see attached 
script).  Individuals who express an interest in participating in this study will be told the 
following to obtain verbal consent:   
 
 
• Investigators Component of Informed Consent:  This study is being conducted by 
Seth A. Creasy at the University of Pittsburgh. His mentor, Dr. John M. Jakicic from the 
Department of Health and Physical Activity will be overseeing this project. 
 
• Description Component of Informed Consent: We are interested in recruiting 60 
men and women to participate in this study. This study will focus on helping you lose 
weight through assisting you to make changes to your eating and activity behaviors. If 
you are eligible for this study you will complete measurements of your physical activity, 
weight, body fatness, fitness, blood pressure, and other factors that may change with 
your participating in this study. You will complete these measures at 0 and 12 weeks 
during this study. Physical activity will also be assessed at weeks 4 and 8. You will 
attend regular weight loss sessions during the intervention period that lasts 12 weeks. 
Also you will be randomly assigned to one of three intervention groups with 
randomization being similar to flipping a coin to decide what group you will be in. One of 
the groups will be asked to complete 12 weeks of supervised physical activity. This 
group will come to the Physical Activity and Weight Management Research Center near 
the University of Pittsburgh’s Oakland Campus to complete these physical activity 
sessions. The other two groups will be asked to complete 12 weeks of home-based 
physical activity, which means you will do all physical activity on your own. The physical 
activity for the home-based groups will be recommended in minutes per week or steps 
per day.  
 
• If you complete this study you can earn up to $95. If you are interested in participating 
in this study, I will need to ask you a few questions about your demographic 
background, physical health, and medical history to determine if you appear to be 
eligible to participate in this study.  It will take approximately 5 minutes to ask you all of 
the questions.  If we complete the interview, I will ask you for some specific information 
(your complete name, phone number and mailing address) so that we can contact you 
regarding your participation in this study.  If eligible, we will then schedule for you to 
attend an orientation session that will explain all of the procedures of this study in 
greater detail.  
 
• Confidentiality Component of Informed Consent: If your answer to a particular 
question tells me clearly that you will not be eligible for this study, I will stop the 
interview, and not ask you any more personal questions. 
 
• Right to Participate or Withdraw from Participation Component of Informed 
Consent: Your responses to these questions are confidential, and the information 
related to your health history or current behaviors that you are about to give me will be 
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 destroyed after this interview even if you are found to be eligible.  
 
Do you have any questions related to any of the information that I have provided to 
you? Staff member will answer any questions or will defer these questions to the 
Principal Investigator or Co-Investigator when appropriate prior to proceeding.  If the 
individual would like to think about their participation prior to proceeding with the Phone 
Screen, they will be provided with the telephone number that they can call if they decide 
to participate in the future. 
 
 
• Voluntary Consent Component of Informed Consent:  Do you agree that the 
procedures that will be used to conduct this Phone Screen have been described to you, 
all of your questions have been answered, and you give me permission to ask you 
questions now as part of the initial Phone Screen?  If “YES” indicate the participant’s 
agreement with this statement on the top of the next page, and sign your name and 
date the form, and then complete the Phone Screen.  If “NO”, thank the individual for 
calling and do not complete the Phone Screen.  
 
 
 
 
 
 
The caller gives verbal permission to conduct the Phone Screen:  Yes No 
 
Verbal Assent was given to: 
 
___________________________________________________ 
Staff Member Signature    
 
_________________________ 
Date Verbal Assent was given 
 
 
 
 
 
 
Completed by Principal Investigator:  
Eligible based on telephone screening:    Yes  No  
If “No”, list reason for ineligibility: _____________________________________ 
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Page 1                         Phone Screen Interview   
 
 
Screening: 
1. Gender:  Male  Female 
2.a. Age:  (18-55)  2.b.Date of Birth: // 
 
3. Current Weight:  pounds  
4. Current Height: feet  inches 
 
Office Use: BMI = _______ (25.0 to <40.0 kg/m2) 
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 Page 2                              Phone Screen Interview 
5. Are you able to walk for exercise?     YES  No  If “no” 
specify reason:_________________________________________ 
 
6. Do you currently exercise regularly at least once per week at a moderate 
intensity for at least 20 minutes?                       
                                             Yes  NO 
If “yes” What types of exercise are you doing?_________________________________ 
If “yes” How many days per week?_________________________________________ 
If “yes” on average how many minutes per day do you exercise?___________________ 
If “yes” How long have you been exercising this way?__________________________ 
 
7. Have you ever been told by a doctor or other medical person that you have any 
of the following conditions? If “yes”, Specify: 
 a. Heart Disease   Yes  NO  ________________________ 
 b. Angina    Yes  NO  ________________________ 
 c. Hypertension   Yes  NO  ________________________ 
 d. Heart Attack   Yes  NO  ________________________ 
 e. Stroke    Yes  NO  ________________________ 
 f.  Diabetes (sugar)   Yes  NO  ________________________ 
 g. Cancer    Yes  NO  ________________________  
 
8. Do you have any joint, bone conditions, or any other medical condition that may 
limit your participation in a physical activity program?      
 If “yes”, specify: ______________________________  Yes  NO 
 
9.  Are you taking any prescription medications for depression or anxiety?  
 Yes  NO 
 
11. Are you taking any medications for your blood pressure? 
If “yes”, specify: _________________________________  Yes  NO 
 
12. Are you taking any medications for your thyroid? 
If “yes”, specify: _________________________________  Yes  NO 
 
13.  Are you taking any medications for the purpose of weight loss?  
 If “yes”, specify: ________________________________   Yes  NO 
 
14. Are you taking any medications that may not be intended for weight loss, but you 
have noticed that the medication may affect your body weight?  
 If “yes”, specify: ________________________________   Yes  NO 
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 Page 3                               Phone Screen Interview 
 
15. Are you currently a member of another organized exercise or are you 
participating in an organized weight reduction program?    
  
If “yes”, specify: _________________________________  Yes  NO 
 
16. Have you lost weight in the past 3 months?    Yes  NO 
 If “yes”, specify number of pounds:_____ Method used:______________ 
 Note: Ineligible if weight loss is ≥5% of current body weight or 15 pounds total 
 
17. Have you undergone bariatric surgery?   Yes  NO  
18. Are you currently being treated for an eating disorder? Yes  NO 
 
19.  Are you currently participating in other research studies?   
  If “yes”, specify: _________________________________  Yes  NO 
 
20.  Have you been a participant in a previous exercise or weight control study?  
 If “yes”, specify: ________________________________   Yes  NO 
 
21. Do you plan to spend any time out of town on vacation or business in the next 6 
months that may affect your ability to participate in the study?   
  
 If “yes”, specify: ________________________________  Yes  NO 
 
 
22. Do you plan on relocating outside of the Greater Pittsburgh Area within the next 6 
months?            
 If “yes”, specify: ______________________________   Yes  NO 
23. Are you currently using an activity tracker? (e.g., Fitbit, Jawbone Up, Shine, etc.) 
  Yes  NO 
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Page 4                               Phone Screen Interview 
 
WOMEN ONLY COMPLETE THE FOLLOWING QUESTIONS 
24. a.    Are you currently pregnant?       Yes NO 
b.  Have you been pregnant in the last 6 months?    Yes  NO 
c.  Do you plan on becoming pregnant in the next 12 weeks?  Yes  NO
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ORIENTATION INVITATION
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 Dear Participant, 
 
You recently contacted the Physical Activity and Weight Management Research Center at the 
University of Pittsburgh inquiring about our current research studies and programs.  We are 
pleased to inform you that we are in the process of beginning our next research program, and based 
on the information that you provided to us at that time, it appears that you are eligible to participate.   
 
As described to you briefly when you called to inquire about this research study, this program is 
designed to place study participants into 1 of 3 groups: (1) supervised physical activity (SUP-PA) 
prescribed in minutes per week plus behavioral intervention sessions, (2) unsupervised physical 
activity (UNSUP-PA) prescribed in minutes per week plus behavioral intervention sessions, or (3) 
Unsupervised physical activity prescribed in steps/day (STEP) plus behavioral intervention 
sessions. All of the groups will receive the same behavioral intervention sessions to promote 
weight loss. These programs will be available to you at no cost. 
 
We would like to invite you to attend an orientation meeting on Wednesday, March 16th at 
5:45 PM in Oak Hill Commons.  We have enclosed a map to assist you in locating this 
building.  Free parking for this orientation is available in the building lot (please refer to the 
enclosed map).  
 
The meeting will last approximately 60-90 minutes.   
 
Please bring a government issued picture identification (driver’s license) with you to this meeting 
that has your name and birth date on it so that we can confirm your age for eligibility in this study. 
 
Please confirm your attendance by calling 412-383-4038 or by emailing sethcreasy@pitt.edu. This 
may be the last orientation session for the study, so if you are able, please try to attend. 
 
Congratulations on taking the first step to better health.  We look forward to working with you! 
 
Sincerely,       
 
 
Seth A. Creasy, MS 
Department of Health and Physical Activity 
Physical Activity and Weight Management Research Center 
 
 
 
Directions to the Physical Activity and Weight Management Research Center 
Oak Hill Commons 
32 Oak Hill Court 
Pittsburgh, PA  15213 (mailing zip code 15261)  
412-383-4020 
NOTE: Because this is a new building this address may not show up when using your 
GPS. Thus, we recommend that you use the directions and map below. 
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From the North 
• Take 279 South 
• Take exit 2A to merge onto I-579 S/Veterans Bridge toward Veterans Bridge 
• Continue to follow I-579 S 
• Take the exit toward Parkway East (376)/Oakland/Monroeville 
• Merge onto Boulevard of the Allies 
• Exit onto Forbes Avenue 
• Turn left onto Craft Avenue 
• Turn left onto Fifth Avenue 
• Take the first right onto Robinson Street 
• Go past the 2nd stop sign at the top of the hill and turn left onto Wadsworth Street 
• At the first stop sign, Oak Hill Drive, make a right 
• Go to the 1st Stop Sign. 
• Our building is just past this stop sign on the right, and the entrance to the parking lot is 
approximately 100 ft past the stop sign on the right. 
 
From the East 
• Take Parkway East (376) 
• Take exit 73B to merge onto PA-885 N/Bates Street toward Oakland 
• Turn left onto Boulevard of the Allies 
• Turn right onto Craft Avenue 
• Turn left onto Fifth Avenue 
• Take the first right onto Robinson Street 
• Go past the 2nd stop sign at the top of the hill and turn left onto Wadsworth Street 
• At the first stop sign, Oak Hill Drive, make a right 
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 • Go to the 1st Stop Sign. 
• Our building is just past this stop sign on the right, and the entrance to the parking lot is 
approximately 100 ft past the stop sign on the right. 
 
From the South or West 
• Take the Parkway West (376) through the Fort Pitt tunnels and the Fort Pitt bridge 
• Keep right to stay on Parkway West (376) 
• Exit onto Forbes Avenue 
• Turn left onto Craft Avenue 
• Turn left onto Fifth Avenue 
• Take the first right onto Robinson Street 
• Go past the 2nd stop sign at the top of the hill and turn left onto Wadsworth Street 
• At the first stop sign, Oak Hill Drive, make a right 
• Go to the 1st Stop Sign. 
• Our building is just past this stop sign on the right, and the entrance to the parking lot is 
approximately 100 ft past the stop sign on the right. 
 
From the South Side 
• Take Carson Street to the Birmingham Bridge 
• Turn left onto Fifth Avenue 
• Take the first right onto Kirkpatrick Street 
• Turn right onto Bentley Drive 
• Turn left onto Oak Hill Drive 
• Go to the 2nd Stop Sign. 
Our building is just past this stop sign on the right, and the entrance to the parking lot is 
approximately 100 ft past the stop sign on the right.
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 APPENDIX D 
REACH ORIENTATION DOCUMENTATION 
 
Table 19. Orientation Schedule 
Orientation Scheduled Number Invited Number Attended Number Consented 
March 2, 2016 12 10 8 
March 3, 2016 16 15 13 
March 8, 2016 19 16 15 
March 16, 2016 25 16 16 
March 18, 2016 10 6 6 
March 23, 2016 2 2 2 
March 30, 2016 5 3 3 
Totals 89 68 63 
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 REACH STUDY 
ALL meetings will be Tuesday @ 5:45pm 
 
 
 
Weekly Meeting Schedule (Weeks 1 – 12)  
 
Figure 16. Behavioral Intervention Meeting Schedule
 
Week 
 
Meeting Date 
Meeting 
 Day 
 
Lesson 
*1 *April 12, 2016 Tuesday Introduction 
*2 *April 19 Tuesday Developing and Implementing an Exercise Plan 
3 April 26 Tuesday Motivation and Goals 
4 May 3 Tuesday Tip the Balance 
5 May 10 Tuesday Evaluating Your Progress/ Assessment Results 
6 May 17 Tuesday Problem Solving and Barriers to Eating and 
Exercise 
7 May 24 Tuesday Thoughts 
8 May 31 Tuesday My Plate/ Dietician 
9 June 7 Tuesday Stimulus Control 
10 June 14 Tuesday Exercise Equivalents 
11 June 21 Tuesday Slippery Slope of Lifestyle Change 
12 June 28 Tuesday Factors Contributing to Long-term Success 
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